<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.0?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mol Syst Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mol. Syst. Biol</journal-id>
    <journal-id journal-id-type="publisher-id">msb</journal-id>
    <journal-title-group>
      <journal-title>Molecular Systems Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1744-4292</issn>
    <issn pub-type="epub">1744-4292</issn>
    <publisher>
      <publisher-name>Blackwell Publishing Ltd</publisher-name>
      <publisher-loc>Oxford, UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4299606</article-id>
    <article-id pub-id-type="pmid">25432777</article-id>
    <article-id pub-id-type="doi">10.15252/msb.20145645</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Potential of fecal microbiota for early-stage detection of colorectal
cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zeller</surname>
          <given-names>Georg</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
        <xref ref-type="author-notes" rid="fn1">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tap</surname>
          <given-names>Julien</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
        <xref ref-type="aff" rid="au2">2</xref>
        <xref ref-type="author-notes" rid="fn1">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Voigt</surname>
          <given-names>Anita Y</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
        <xref ref-type="aff" rid="au3">3</xref>
        <xref ref-type="aff" rid="au4">4</xref>
        <xref ref-type="aff" rid="au5">5</xref>
        <xref ref-type="author-notes" rid="fn1">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sunagawa</surname>
          <given-names>Shinichi</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kultima</surname>
          <given-names>Jens Roat</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Costea</surname>
          <given-names>Paul I</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Amiot</surname>
          <given-names>Aurélien</given-names>
        </name>
        <xref ref-type="aff" rid="au2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Böhm</surname>
          <given-names>Jürgen</given-names>
        </name>
        <xref ref-type="aff" rid="au6">6</xref>
        <xref ref-type="aff" rid="au7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brunetti</surname>
          <given-names>Francesco</given-names>
        </name>
        <xref ref-type="aff" rid="au8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Habermann</surname>
          <given-names>Nina</given-names>
        </name>
        <xref ref-type="aff" rid="au6">6</xref>
        <xref ref-type="aff" rid="au7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hercog</surname>
          <given-names>Rajna</given-names>
        </name>
        <xref ref-type="aff" rid="au9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Koch</surname>
          <given-names>Moritz</given-names>
        </name>
        <xref ref-type="aff" rid="au10">10</xref>
        <xref ref-type="author-notes" rid="fn2">‡</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Luciani</surname>
          <given-names>Alain</given-names>
        </name>
        <xref ref-type="aff" rid="au11">11</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mende</surname>
          <given-names>Daniel R</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schneider</surname>
          <given-names>Martin A</given-names>
        </name>
        <xref ref-type="aff" rid="au10">10</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Schrotz-King</surname>
          <given-names>Petra</given-names>
        </name>
        <xref ref-type="aff" rid="au6">6</xref>
        <xref ref-type="aff" rid="au7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tournigand</surname>
          <given-names>Christophe</given-names>
        </name>
        <xref ref-type="aff" rid="au12">12</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tran Van Nhieu</surname>
          <given-names>Jeanne</given-names>
        </name>
        <xref ref-type="aff" rid="au13">13</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yamada</surname>
          <given-names>Takuji</given-names>
        </name>
        <xref ref-type="aff" rid="au14">14</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zimmermann</surname>
          <given-names>Jürgen</given-names>
        </name>
        <xref ref-type="aff" rid="au9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Benes</surname>
          <given-names>Vladimir</given-names>
        </name>
        <xref ref-type="aff" rid="au9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kloor</surname>
          <given-names>Matthias</given-names>
        </name>
        <xref ref-type="aff" rid="au3">3</xref>
        <xref ref-type="aff" rid="au4">4</xref>
        <xref ref-type="aff" rid="au5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ulrich</surname>
          <given-names>Cornelia M</given-names>
        </name>
        <xref ref-type="aff" rid="au6">6</xref>
        <xref ref-type="aff" rid="au7">7</xref>
        <xref ref-type="aff" rid="au15">15</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>von Knebel Doeberitz</surname>
          <given-names>Magnus</given-names>
        </name>
        <xref ref-type="aff" rid="au3">3</xref>
        <xref ref-type="aff" rid="au4">4</xref>
        <xref ref-type="aff" rid="au5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sobhani</surname>
          <given-names>Iradj</given-names>
        </name>
        <xref ref-type="aff" rid="au2">2</xref>
        <xref ref-type="corresp" rid="cor1">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bork</surname>
          <given-names>Peer</given-names>
        </name>
        <xref ref-type="aff" rid="au1">1</xref>
        <xref ref-type="aff" rid="au5">5</xref>
        <xref ref-type="aff" rid="au16">16</xref>
        <xref ref-type="corresp" rid="cor2">**</xref>
      </contrib>
      <aff id="au1">
        <label>1</label>
        <institution>Structural and Computational Biology Unit, European
Molecular Biology Laboratory</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au2">
        <label>2</label>
        <institution>Department of Gastroenterology and LIC-EA4393-EC2M3, APHP
and UPEC Université Paris-Est Créteil</institution>
        <addr-line>Créteil, France</addr-line>
      </aff>
      <aff id="au3">
        <label>3</label>
        <institution>Department of Applied Tumor Biology, Institute of
Pathology, University Hospital Heidelberg</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au4">
        <label>4</label>
        <institution>Clinical Cooperation Unit Applied Tumor Biology, German
Cancer Research Center (DKFZ)</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au5">
        <label>5</label>
        <institution>Molecular Medicine Partnership Unit (MMPU), University
Hospital Heidelberg and European Molecular Biology Laboratory</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au6">
        <label>6</label>
        <institution>Division of Preventive Oncology, National Center for
Tumor Diseases (NCT) Heidelberg</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au7">
        <label>7</label>
        <institution>German Cancer Research Center (DKFZ)</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au8">
        <label>8</label>
        <institution>Department of Surgery, APHP and UPEC Université
Paris-Est Créteil</institution>
        <addr-line>Créteil, France</addr-line>
      </aff>
      <aff id="au9">
        <label>9</label>
        <institution>Genomics Core Facility, European Molecular Biology
Laboratory</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au10">
        <label>10</label>
        <institution>Department of General, Visceral and Transplantation
Surgery, University Hospital Heidelberg</institution>
        <addr-line>Heidelberg, Germany</addr-line>
      </aff>
      <aff id="au11">
        <label>11</label>
        <institution>Department of Radiology, APHP and UPEC
Université Paris-Est Créteil</institution>
        <addr-line>Créteil, France</addr-line>
      </aff>
      <aff id="au12">
        <label>12</label>
        <institution>Department of Medical Oncology, APHP and UPEC
Université Paris-Est Créteil</institution>
        <addr-line>Créteil, France</addr-line>
      </aff>
      <aff id="au13">
        <label>13</label>
        <institution>Department of Pathology and LIC-EA4393-EC2M3, APHP and
UPEC Université Paris-Est Créteil</institution>
        <addr-line>Créteil, France</addr-line>
      </aff>
      <aff id="au14">
        <label>14</label>
        <institution>Department of Biological Information, Tokyo Institute
of Technology</institution>
        <addr-line>Tokyo, Japan</addr-line>
      </aff>
      <aff id="au15">
        <label>15</label>
        <institution>Fred Hutchinson Cancer Research Center
(FHCRC)</institution>
        <addr-line>Seattle, WA, USA</addr-line>
      </aff>
      <aff id="au16">
        <label>16</label>
        <institution>Max Delbrück Centre for Molecular
Medicine</institution>
        <addr-line>Berlin, Germany</addr-line>
      </aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1">*Corresponding author. Tel: +33 1 49814358; E-mail:
<email>iradj.sobhani@hmn.aphp.fr</email></corresp>
      <corresp id="cor2">**Corresponding author. Tel: +49 6221 3878361; E-mail:
<email>bork@embl.de</email></corresp>
      <fn id="fn1">
        <label>†</label>
        <p>These authors contributed equally to this work</p>
      </fn>
      <fn id="fn2" fn-type="present-address">
        <label>‡</label>
        <p>Present address: Department of Abdominal, Thoracic and Vascular Surgery, University Hospital Carl
Gustav Carus, Technical University Dresden, Dresden, Germany</p>
      </fn>
      <fn>
        <p><bold>Subject Categories</bold> Cancer; Systems Medicine</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <month>11</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>28</day>
      <month>11</month>
      <year>2014</year>
    </pub-date>
    <volume>10</volume>
    <issue>11</issue>
    <elocation-id>766</elocation-id>
    <history>
      <date date-type="received">
        <day>01</day>
        <month>8</month>
        <year>2014</year>
      </date>
      <date date-type="rev-recd">
        <day>12</day>
        <month>11</month>
        <year>2014</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>11</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2014 The Authors. Published under the terms of the CC BY 4.0
license</copyright-statement>
      <copyright-year>2014</copyright-year>
      <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article under the terms of the Creative Commons Attribution 4.0 License,
which permits use, distribution and reproduction in any medium, provided the original work is
properly cited.</license-p>
      </license>
    </permissions>
    <abstract>
      <p>Several bacterial species have been implicated in the development of colorectal carcinoma (CRC),
but CRC-associated changes of fecal microbiota and their potential for cancer screening remain to be
explored. Here, we used metagenomic sequencing of fecal samples to identify taxonomic markers that
distinguished CRC patients from tumor-free controls in a study population of 156 participants.
Accuracy of metagenomic CRC detection was similar to the standard fecal occult blood test (FOBT) and
when both approaches were combined, sensitivity improved &gt; 45% relative to the FOBT,
while maintaining its specificity. Accuracy of metagenomic CRC detection did not differ
significantly between early- and late-stage cancer and could be validated in independent patient and
control populations (<italic>N</italic> = 335) from different countries. CRC-associated
changes in the fecal microbiome at least partially reflected microbial community composition at the
tumor itself, indicating that observed gene pool differences may reveal tumor-related
host–microbe interactions. Indeed, we deduced a metabolic shift from fiber degradation in
controls to utilization of host carbohydrates and amino acids in CRC patients, accompanied by an
increase of lipopolysaccharide metabolism.</p>
    </abstract>
    <kwd-group>
      <kwd>cancer screening</kwd>
      <kwd>colorectal cancer</kwd>
      <kwd>fecal biomarkers</kwd>
      <kwd>human gut microbiome</kwd>
      <kwd>metagenomics</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec>
    <title>Introduction</title>
    <p>Colorectal carcinoma (CRC) is among the three most common cancers with more than 1.2 million new
cases and about 600,000 deaths per year worldwide (Jemal <italic>et al</italic>, <xref rid="b42" ref-type="bibr">2011</xref>). In most cases, initial genomic alterations, for example, in
the <italic>APC/Wnt</italic> signaling pathway, cause hyperproliferation, which can lead to the
formation of adenomas, and finally invasive carcinomas upon accumulation of further driver mutations
(Cancer Genome Atlas Network, <xref rid="b13" ref-type="bibr">2012</xref>; Vogelstein <italic>et
al</italic>, <xref rid="b88" ref-type="bibr">2013</xref>). If CRC is diagnosed early, when it is
still localized (American Joint Committee on Cancer (AJCC) stages 0, I, or II), the 5-year survival
rate is &gt; 80%, but decreases to &lt; 10% for late diagnosis of metastasized
cancer (in AJCC stage IV) (O'Connell <italic>et al</italic>, <xref rid="b63" ref-type="bibr">2004</xref>). Therefore, population-wide screening and prevention programs are recommended in many
countries. Fecal occult blood testing (Hemoccult FOBT) is currently the standard noninvasive
screening test (Levin <italic>et al</italic>, <xref rid="b53" ref-type="bibr">2008</xref>; Zavoral
<italic>et al</italic>, <xref rid="b96" ref-type="bibr">2009</xref>). However, because FOBT has
limited sensitivity and specificity for CRC and does not reliably detect precancerous lesions
(Allison <italic>et al</italic>, <xref rid="b2" ref-type="bibr">1996</xref>; Faivre <italic>et
al</italic>, <xref rid="b28" ref-type="bibr">2004</xref>), there is an urgent demand for more
accurate screening tests to identify patients who should undergo colonoscopy, which is considered
the most effective diagnostic method (Levin <italic>et al</italic>, <xref rid="b53" ref-type="bibr">2008</xref>).</p>
    <p>As the majority of CRC cases are thought to be of a sporadic nature rather than due to
inheritance (Lichtenstein <italic>et al</italic>, <xref rid="b56" ref-type="bibr">2000</xref>),
environmental risk factors have been investigated for a long time, but only recently have microbes
colonizing the gut been considered as potential cancer-promoting factors. While in gastric, hepatic,
and cervical cancers, a causal role is established for a single infectious agent in each case,
namely <italic>Helicobacter pylori</italic>, hepatitis B virus, and human papillomaviruses,
respectively (de Martel <italic>et al</italic>, <xref rid="b59" ref-type="bibr">2012</xref>), in
CRC, a variety of bacterial species and tumor-promoting virulence mechanisms have been investigated,
mostly in cell lines and mouse models. For example, <italic>Bacteroides fragilis</italic> strains
producing genotoxins (BFTs) can induce inflammation, leading to DNA damage in host cells (Wu
<italic>et al</italic>, <xref rid="b93" ref-type="bibr">2009</xref>; Goodwin <italic>et al</italic>,
<xref rid="b37" ref-type="bibr">2011</xref>); similarly, <italic>Escherichia coli</italic> strains
harboring a genomic virulence island (<italic>pks</italic>) can cause DNA damage and chromosomal
instability in the host (Cuevas-Ramos <italic>et al</italic>, <xref rid="b20" ref-type="bibr">2010</xref>; Arthur <italic>et al</italic>, <xref rid="b5" ref-type="bibr">2012</xref>), and very
recently, <italic>Fusobacterium nucleatum</italic> strains were reported to promote carcinogenesis
upon invasion of host cells (Kostic <italic>et al</italic>, <xref rid="b48" ref-type="bibr">2013</xref>; Rubinstein <italic>et al</italic>, <xref rid="b71" ref-type="bibr">2013</xref>).
However, it remains unclear how many CRC cases can be attributed to each of these agents, how these
exactly interact with the human host or the microbial community in the gut, and whether altered
microbial abundances may provide a basis for an accurate CRC screening test.</p>
    <p>Obtaining a comprehensive view of the microbial ecosystem in our gut—the
microbiome—has become possible with high-throughput environmental sequencing techniques (Qin
<italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>; Human Microbiome Project
Consortium, <xref rid="b40" ref-type="bibr">2012</xref>), and a number of reports have associated
gut microbiota with diseases, such as obesity, type 2 diabetes, and atherosclerosis (e.g., Karlsson
<italic>et al</italic>, <xref rid="b44" ref-type="bibr">2013</xref>; Koeth <italic>et al</italic>,
<xref rid="b46" ref-type="bibr">2013</xref>; Le Chatelier <italic>et al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>; Qin <italic>et al</italic>, <xref rid="b69" ref-type="bibr">2012</xref>; Turnbaugh <italic>et al</italic>, <xref rid="b85" ref-type="bibr">2009</xref>).
Several medium-scale studies recently characterized the microbiota of colonic tumor biopsies
compared to healthy mucosa either by quantifying the 16S rRNA phylogenetic marker gene or by
metatranscriptomic sequencing (Marchesi <italic>et al</italic>, <xref rid="b58" ref-type="bibr">2011</xref>; Castellarin <italic>et al</italic>, <xref rid="b18" ref-type="bibr">2012</xref>;
Kostic <italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>; McCoy <italic>et
al</italic>, <xref rid="b60" ref-type="bibr">2013</xref>; Warren <italic>et al</italic>, <xref rid="b91" ref-type="bibr">2013</xref>; Flanagan <italic>et al</italic>, <xref rid="b32" ref-type="bibr">2014</xref>; Tahara <italic>et al</italic>, <xref rid="b81" ref-type="bibr">2014</xref>).
Even though these consistently documented an enrichment of members of the
<italic>Fusobacterium</italic> genus, the relevance of these or other microbial agents for
noninvasive CRC screening remains unclear.</p>
    <p>Here, we systematically investigate the potential of fecal microbiota for noninvasive detection
of colorectal cancer in several patient populations from different countries.</p>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <sec>
      <title>The gut microbiome of a French CRC study population</title>
      <p>To explore associations between the gut microbiome and colorectal carcinoma (CRC), we first
analyzed fecal metagenomes from a population of 156 participants recruited in France (study
population F in the following, see Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary
Table S1 and Supplementary Dataset S1 for patient data), who underwent colonoscopy to either
diagnose colorectal neoplasia in the form of adenoma(s) (polyps) or CRC, or confirm the absence of
these. Carcinomas were further classified according to established staging systems (AJCC and TNM)
(O'Connell <italic>et al</italic>, <xref rid="b63" ref-type="bibr">2004</xref>). We first
analyzed global community properties: While CRC-associated dysbiosis did not result in significant
changes of microbial community diversity or richness (Supplementary Fig S1D and F), the distribution
of enterotypes, as a descriptor of global community structure (Arumugam <italic>et al</italic>,
<xref rid="b7" ref-type="bibr">2011</xref>), varied slightly, but significantly between patient
groups (Supplementary Fig S1A and B). We further observed significant differences in the abundance
of specific taxa (Kultima <italic>et al</italic>, <xref rid="b50" ref-type="bibr">2012</xref>)
(Supplementary Fig S2). The gram-negative phyla of Fusobacteria and, to a lesser extent,
Proteobacteria were significantly increased in CRC patients, whereas Actinobacteria were decreased.
Bacteroidetes and Firmicutes were enriched and depleted, respectively, in CRC patients
(consequently, also the ratio between these two phyla (Turnbaugh <italic>et al</italic>, <xref rid="b86" ref-type="bibr">2006</xref>) differed significantly, see Supplementary Fig S1C).</p>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Summary of study population F, G, and H</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="5" colspan="1">Study population</th>
              <th align="left" rowspan="5" colspan="1">Healthy</th>
              <th align="left" colspan="2" rowspan="1">Adenoma</th>
              <th align="left" colspan="5" rowspan="1">Colorectal cancer</th>
              <th align="left" rowspan="5" colspan="1">Country of residence</th>
            </tr>
            <tr>
              <th align="left" colspan="2" rowspan="1">
                <hr/>
              </th>
              <th align="left" colspan="5" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="left" rowspan="3" colspan="1">Small (&lt; 1 cm)</th>
              <th align="left" rowspan="3" colspan="1">Large (≥ 1 cm)</th>
              <th align="left" colspan="3" rowspan="1">Early stages<xref ref-type="table-fn" rid="tf1-3">c</xref></th>
              <th align="left" colspan="2" rowspan="1">Late stage<xref ref-type="table-fn" rid="tf1-3">c</xref></th>
            </tr>
            <tr>
              <th align="left" colspan="3" rowspan="1">
                <hr/>
              </th>
              <th align="left" colspan="2" rowspan="1">
                <hr/>
              </th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">0</th>
              <th align="left" rowspan="1" colspan="1">I</th>
              <th align="left" rowspan="1" colspan="1">II</th>
              <th align="left" rowspan="1" colspan="1">III</th>
              <th align="left" rowspan="1" colspan="1">IV</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">F (<italic>N</italic> = 156)<xref ref-type="table-fn" rid="tf1-1">a</xref></td>
              <td align="left" rowspan="1" colspan="1">61</td>
              <td align="left" rowspan="1" colspan="1">27</td>
              <td align="left" rowspan="1" colspan="1">15</td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" rowspan="1" colspan="1">15</td>
              <td align="left" rowspan="1" colspan="1">7</td>
              <td align="left" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">21</td>
              <td align="left" rowspan="1" colspan="1">France</td>
            </tr>
            <tr>
              <td align="left" colspan="10" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">G (<italic>N</italic> = 38)<xref ref-type="table-fn" rid="tf1-1">a</xref></td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" colspan="3" rowspan="1">25</td>
              <td align="left" colspan="2" rowspan="1">13</td>
              <td align="left" rowspan="1" colspan="1">Germany</td>
            </tr>
            <tr>
              <td align="left" colspan="10" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">H (<italic>N</italic> = 297)<xref ref-type="table-fn" rid="tf1-2">b</xref></td>
              <td align="left" rowspan="1" colspan="1">297</td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" rowspan="1" colspan="1">0</td>
              <td align="left" colspan="3" rowspan="1">0</td>
              <td align="left" colspan="2" rowspan="1">0</td>
              <td align="left" rowspan="1" colspan="1">Denmark<xref ref-type="table-fn" rid="tf1-4">d</xref>, Spain<xref ref-type="table-fn" rid="tf1-5">e</xref>, Germany</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tf1-1">
            <label>a</label>
            <p>Disease status confirmed by colonoscopy.</p>
          </fn>
          <fn id="tf1-2">
            <label>b</label>
            <p>Absence of neoplasias not assessed by colonoscopy.</p>
          </fn>
          <fn id="tf1-3">
            <label>c</label>
            <p>AJCC staging.</p>
          </fn>
          <fn id="tf1-4">
            <label>d</label>
            <p>Published in Qin <italic>et al</italic> (<xref rid="b68" ref-type="bibr">2010</xref>) and Le
Chatelier <italic>et al</italic> (<xref rid="b51" ref-type="bibr">2013</xref>).</p>
          </fn>
          <fn id="tf1-5">
            <label>e</label>
            <p>Published in Qin <italic>et al</italic> (<xref rid="b68" ref-type="bibr">2010</xref>).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>When comparing patients with adenomas (of any size) to neoplasia-free controls and to CRC
patients in terms of their microbiota composition, we found them to be almost indistinguishable from
neoplasia-free participants (significant differences, except for the <italic>Ruminococcus</italic>
genus, could not be detected). Additionally, many of the CRC-specific changes were seen in the
comparison to both neoplasia-free participants and adenoma patients (Supplementary Fig S2). For
subsequent analyses of the CRC-associated microbiota, we therefore included patients with small
adenomas (diameter &lt; 10 mm) in the control group, whereas large adenomas as clinically
significant precursors of CRC were excluded from these comparisons as has been done in other CRC
screening studies before (Imperiale <italic>et al</italic>, <xref rid="b41" ref-type="bibr">2014</xref>).</p>
    </sec>
    <sec>
      <title>A metagenomic classifier for CRC</title>
      <p>To explore the suitability of gut microbiota for CRC detection, we evaluated the predictive power
of global measures of taxonomic community composition. While these differed significantly between
CRC patients and controls (Supplementary Fig S1G–J), they would not allow for accurate CRC
detection, as quantified by an area under the receiver operating characteristic (ROC) curve (AUC) of
0.73 (Supplementary Fig S1K). As individual species abundance differences were already more
discriminative (AUCs up to 0.75; Supplementary Fig S3), we hypothesized that a combination of marker
species would lead to improved detection accuracy. To this end, we adopted a classification
methodology based on penalized linear models (see Materials and Methods) (Tibshirani, <xref rid="b83" ref-type="bibr">1996</xref>). The consensus signature, extracted from an ensemble of
classifiers (see Materials and Methods) that were trained on taxonomic abundance profiles, consisted
of 22 species (Fig <xref ref-type="fig" rid="fig01">1</xref>A). On average, &gt; 51% of
the total absolute weight of these classification models can be attributed to the abundance
differences of only the four most discriminative species: two <italic>Fusobacterium</italic>
species, <italic>Porphyromonas asaccharolytica</italic> and <italic>Peptostreptococcus
stomatis</italic>, all of which are enriched in CRC (Fig <xref ref-type="fig" rid="fig01">1</xref>A). Although it is not yet clear whether and which gut microbiota are causally involved in
CRC, recent evidence suggests <italic>Fusobacterium</italic> species (in particular <italic>F.
nucleatum</italic>) to be prevalent CRC-associated microbes (Castellarin <italic>et al</italic>,
<xref rid="b18" ref-type="bibr">2012</xref>; Kostic <italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>) and to accelerate tumorigenesis (Kostic <italic>et al</italic>, <xref rid="b48" ref-type="bibr">2013</xref>; Rubinstein <italic>et al</italic>, <xref rid="b71" ref-type="bibr">2013</xref>). Here, we further refine this association to the two subspecies <italic>F.
nucleatum vincentii</italic> and <italic>F. nucleatum animalis</italic>, both of which are distinct
enough from <italic>F. nucleatum</italic> subsp. <italic>nucleatum</italic> and from each other to
qualify as independent species (Supplementary Fig S4A) (Mende <italic>et al</italic>, <xref rid="b62" ref-type="bibr">2013</xref>). While <italic>Fusobacterium</italic> is a promising
candidate for a causal agent, only classification models with additional species resulted in precise
CRC detection (Supplementary Figs S1G–K, S3 and S4). When cross-validating the metagenomic
classifiers on study population F, an AUC of 0.84 was achieved (Fig <xref ref-type="fig" rid="fig01">1</xref>B).</p>
      <fig id="fig01" position="float">
        <label>Figure 1</label>
        <caption>
          <title>Signature of CRC-associated gut microbial species</title>
          <p>
            <list list-type="alpha-upper">
              <list-item>
                <p>Relative abundances of 22 gut microbial species, collectively associated with CRC, are displayed
as heatmap in the left panel as fold change over the median relative abundance observed in controls
(indicated to the right); the control group included neoplasia-free and small adenoma patients. The
mean contribution of each marker species to the classification is shown to the right (bars
correspond to log-odds ratio in logistic regression; numbers indicate percentage of absolute total
weight, see Materials and Methods). Different cancer stages are color-coded below the heatmap (see
Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1 and Supplementary Dataset
S1 for patient data). Below, the classification score of the microbial signature (from
cross-validation) is shown as gray scale (see key) with the decision boundary and resulting false
positives and true positives indicated in red (using colonoscopy results as a ground truth).
Displayed alongside are the results of the standard Hemoccult FOBT routinely applied for CRC
screening and an experimental CRC screening test based on methylation of the <italic>wif-1</italic>
gene, a <italic>Wnt</italic> pathway member (Lee <italic>et al</italic>, <xref rid="b52" ref-type="bibr">2009</xref>; Mansour &amp; Sobhani, <xref rid="b57" ref-type="bibr">2009</xref>) (see
main text for details).</p>
              </list-item>
              <list-item>
                <p>Test accuracy of the metagenomic classifier is depicted as ROC curve summarizing mean test
predictions made in ten times resampled tenfold cross-validation on study population F
(<italic>N</italic> = 141, 95% confidence intervals of true-positive rate are shaded,
see Materials and Methods and Table <xref ref-type="table" rid="tbl1">1</xref>). Additionally, the
accuracy of the <italic>wif-1</italic> methylation test (Lee <italic>et al</italic>, <xref rid="b52" ref-type="bibr">2009</xref>; Mansour &amp; Sobhani, <xref rid="b57" ref-type="bibr">2009</xref>) as well as of the FOBT is shown (as assessed for the same patients). A combination
test, in which the FOBT results and microbial abundance profiles were jointly used as predictors,
resulted in significantly enhanced accuracy over both the metagenomic classifier and the FOBT alone,
compared to which the relative gain in sensitivity is &gt; 45% at the same specificity
(*denotes one-sided bootstrapping <italic>P</italic>-values &lt; 0.05 of TPR improvement
over FOBT and of difference in the whole ROC curve to the metagenomic test, respectively, see
Materials and Methods). All screening tests are evaluated relative to colonoscopy findings (see key
and main text for details; see also Supplementary Figs S4, S5 and S6 for additional details on the
classifier, and Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1 and
Supplementary Dataset S1 for patient data).</p>
              </list-item>
              <list-item>
                <p>When applied to the larger study populations G and H (335 metagenomes from several countries
including 38 from German CRC patients) for external validation, the metagenomic classifier achieved
very similar accuracy as in cross-validation, as measured by the area under the ROC curve (AUC) of
mean test prediction scores (ROC curve and confidence intervals as in (A); see also Supplementary
Figs S5 and S6 and Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1 and
Supplementary Dataset S1).</p>
              </list-item>
              <list-item>
                <p>Sensitivity (TPR) of the metagenomic classifier for carcinomas in early stages (AJCC stages 0, I,
and II) was similar as for late-stage, metastasizing CRC (AJCC stages III and IV) in both study
populations F and G highlighting its potential utility for early detection (see also Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1 and Supplementary Dataset S1).</p>
              </list-item>
              <list-item>
                <p>Although the classifier associated species with a binary grouping into cancer and non-cancer
patients, several of them exhibited gradual abundance changes over the progression from
neoplasia-free participants over adenoma to early- and late-stage cancer patients (see key below A);
displayed are the 4 most discriminative CRC marker species, each of which shows a Spearman
correlation (rho) with cancer progression (grouped as in A) that is stronger than 0.2 with
<italic>P</italic>-values &lt; 0.001. Significant changes in early-stage CRC patients compared
to neoplasia-free controls are marked (*<italic>P</italic> &lt; 0.05,
**<italic>P</italic> &lt; 1E-5, Wilcoxon test). Vertical black lines indicate
median relative abundance with gray boxes denoting the inter-quartile range; gray whiskers extend to
the 5<sup>th</sup> and 95<sup>th</sup> percentile (see also Supplementary Fig S7).</p>
              </list-item>
            </list>
          </p>
          <p>Source data are available online for this figure.</p>
        </caption>
        <graphic xlink:href="msb0010-0766-f1"/>
      </fig>
      <p>Whereas cases and controls in this study population were characterized by a similar distribution
of gender and body mass index (BMI), CRC patients were significantly older on average (Supplementary
Table S1 and Supplementary Fig S5A–D). To investigate this potential source of confounding,
we trained a CRC classifier based on patient characteristics (gender, age, and BMI) alone and found
it to have a cross-validation accuracy of 0.63, significantly less than the metagenomic classifier
(Supplementary Fig S5E). Additionally, we tested whether the metagenomic classifier exploits
potential correlations of microbial abundances with host age rather than with CRC, which would
result in spurious CRC predictions for older subjects. However, the classifier showed an increase
neither in false-positive rate nor in sensitivity for older patients (Supplementary Fig S5F and
G).</p>
      <p>In our study population, the accuracy of the metagenomic classifier was slightly better than that
of the Hemoccult FOBT (Fig <xref ref-type="fig" rid="fig01">1</xref>B); this test, basically
detecting traces of blood in feces, is routinely used in mass screening for CRC (Allison <italic>et
al</italic>, <xref rid="b2" ref-type="bibr">1996</xref>; Faivre <italic>et al</italic>, <xref rid="b28" ref-type="bibr">2004</xref>; Zavoral <italic>et al</italic>, <xref rid="b96" ref-type="bibr">2009</xref>) and was also applied to participants prior to colonoscopy. The accuracy of
another experimental screening assay based on a different readout, namely the level of gene
methylation of the <italic>Wnt</italic> signaling pathway member, <italic>wif-1</italic> (Lee
<italic>et al</italic>, <xref rid="b52" ref-type="bibr">2009</xref>; Mansour &amp; Sobhani, <xref rid="b57" ref-type="bibr">2009</xref>), was also matched by the metagenomic test (Fig <xref ref-type="fig" rid="fig01">1</xref>B). As the features captured by FOBT and the metagenome appeared
to be partially independent (Fig <xref ref-type="fig" rid="fig01">1</xref>A), we also evaluated a
combination test. This significantly improved accuracy to an AUC of 0.87, corresponding to a
considerable relative gain in sensitivity (i.e., TPR) of &gt; 45% over the FOBT alone
(Fig <xref ref-type="fig" rid="fig01">1</xref>B).</p>
    </sec>
    <sec>
      <title>Validation of the CRC classifier using patients and controls from different countries</title>
      <p>The broad utility of gut microbial markers might be limited by geographical or ethnical
particularities or by technical variations in experimental procedures (Sunagawa <italic>et
al</italic>, <xref rid="b80" ref-type="bibr">2013</xref>; de Vos &amp; Nieuwdorp, <xref rid="b89" ref-type="bibr">2013</xref>), as illustrated by distinct microbial associations with type
2 diabetes in Chinese and Swedish studies (Qin <italic>et al</italic>, <xref rid="b69" ref-type="bibr">2012</xref>; Karlsson <italic>et al</italic>, <xref rid="b44" ref-type="bibr">2013</xref>). We therefore sought to validate the metagenomic CRC classifier in an independent
group of individuals from different countries (see Materials and Methods). To assess whether it
maintains high specificity in a large control population, we applied the classifier to five samples
from healthy individuals living in Germany and 292 published fecal metagenomes from Danish and
Spanish individuals who were diagnosed with neither CRC nor inflammatory bowel disease (IBD) (Qin
<italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>; Le Chatelier <italic>et
al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>) (study population H, see Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1 and Supplementary Dataset S1). At a
decision boundary of 0.275 (i.e., the value above which the classifier predicts CRC, Fig <xref ref-type="fig" rid="fig01">1</xref>), the resulting false-positive rate (i.e., 1 −
specificity) varied slightly from 8.0 to 7.7% between cross-validation on study population F
and independent validation on study population H (Supplementary Fig S6A). In these validation
populations, the true error rate might be slightly overestimated, because absence of CRC has not
been confirmed by colonoscopy. To also independently validate the sensitivity of the classifier, we
sequenced an additional 38 fecal metagenomes from individuals who were diagnosed with CRC by
colonoscopy in a German hospital (study population G, see Table <xref ref-type="table" rid="tbl1">1</xref>,Supplementary Table S1 and Supplementary Dataset S1). On this dataset, the sensitivity
(i.e., true-positive rate) of the metagenomic CRC classifier was 52.6% compared to
58.5% observed in cross-validation (Supplementary Fig S6B). On the combined validation set of
study populations F and H, the metagenomic CRC classifier achieved an accuracy of 0.85 AUC,
virtually the same value obtained in cross-validation of population F (Fig <xref ref-type="fig" rid="fig01">1</xref>B and C). Taken together, these results indicate that, despite differences
between study populations in nationality and demographics, metagenomic CRC detection is possible
with high accuracy, broadly applicable and robust to technical variation.</p>
      <p>In order to assess the potential improvement of classification accuracy with a larger study
population, we included the 38 CRC patients from study population G into study population F and
applied the same modeling approach to train and cross-validate a more comprehensive classifier (see
Materials and Methods). Its cross-validation accuracy increased to 0.90 AUC (Supplementary Fig S6C
and G), which illustrates the future promise of large, multicenter cohort studies investigating the
role of the microbiota in this disease.</p>
    </sec>
    <sec>
      <title>Detection of CRC in different stages of tumor progression</title>
      <p>As an instrument for reducing CRC mortality, patient screening is most effective if cancer is
diagnosed early, before the tumor has metastasized to nearby lymph nodes or distant tissues
(O'Connell <italic>et al</italic>, <xref rid="b63" ref-type="bibr">2004</xref>). To rule out
that our metagenomic classifier is biased toward late-stage carcinomas, for which changes in the
colon environment and its microbiota might be more pronounced than in earlier stages of tumor
development, we compared the sensitivity for localized early-stage CRC (AJCC stages 0, I, and II) to
that for metastasized late-stage tumors (AJCC stages III and IV). We found that early-stage CRC was
detected with a sensitivity comparable to metastasized tumors in both study populations F and G (Fig
<xref ref-type="fig" rid="fig01">1</xref>D), confirming the potential of microbial markers for early
detection of CRC. Additionally, we explored how the abundances of the four most discriminative CRC
markers correlated with CRC progression from early neoplastic growth to late-stage metastasizing
tumors (with samples stratified into four groups of neoplasia-free participants, participants with
adenomas, stage 0/I/II, and stage III/IV CRC patients) (Fig <xref ref-type="fig" rid="fig01">1</xref>D). All of these markers showed a significant correlation (all Spearman
<italic>P</italic>-values &lt; 0.001), and a strong enrichment in early-stage CRC patients
compared to controls was evident for both <italic>Fusobacterium</italic> species and
<italic>Peptostreptococcus stomatis</italic> (Fig <xref ref-type="fig" rid="fig01">1</xref>E).
Likewise, depletion of some microbes in cancer patients (i.e., negatively associated with CRC), such
as <italic>Eubacterium</italic> spp. <italic>rectale</italic> and <italic>eligens</italic> and
<italic>Streptococcus salivarius</italic>, was already noticeable in early stages (Supplementary Fig
S7).</p>
    </sec>
    <sec>
      <title>CRC marker species in inflammatory bowel disease</title>
      <p>The observed associations of microbiota with CRC alone do not reveal how specific they are to
this particular disease. To exclude that there might be a more general dysbiosis common to multiple
disease conditions (e.g., due to inflammation), we applied our classifier to 25 recently published
metagenomes from inflammatory bowel disease (IBD) patients (21 ulcerative colitis (UC) and four
Crohn's disease (CD) patients, see Supplementary Dataset S1) (Qin <italic>et al</italic>,
<xref rid="b68" ref-type="bibr">2010</xref>). Although small sample size precludes precise
estimates, our results indicate a moderate increase of false-positive predictions to 24% in
these patients, about three times the rate seen in other controls (Fig <xref ref-type="fig" rid="fig02">2</xref>A). This may reflect common alterations in the microbiota in these diseases,
which is consistent with IBD patients being at greater risk of developing CRC (Bernstein <italic>et
al</italic>, <xref rid="b11" ref-type="bibr">2001</xref>). To explore this further, we monitored the
four most discriminative CRC marker species for significant changes in abundance in IBD patients
relative to controls (Fig <xref ref-type="fig" rid="fig02">2</xref>B). Although higher prevalence of
<italic>Fusobacterium</italic> species in IBD patients has been reported (Strauss <italic>et
al</italic>, <xref rid="b79" ref-type="bibr">2011</xref>), we did not observe a significant increase
for the two CRC marker species from this genus in IBD patients, which is consistent with a recent
study that showed an increase of <italic>Fusobacterium</italic> abundance in IBD patients'
mucosal tissue, but did not detect an enrichment in stool (Gevers <italic>et al</italic>, <xref rid="b36" ref-type="bibr">2014</xref>). For the most discriminative marker species that our model
positively associated with CRC, we found significantly higher levels in CRC compared to IBD
patients, indicating that these markers are specific to CRC (Fig <xref ref-type="fig" rid="fig02">2</xref>B). Generally, stronger associations were observed with CRC than with IBD for most marker
species (Supplementary Fig S8), suggesting that the metagenomic classifier is specific for CRC and
is only modestly influenced by changes in the microbiota that are due to inflammation. However, to
broadly compare changes in the gut microbiome across gastrointestinal disorders, larger studies on
IBD and other inflammatory diseases will be needed.</p>
      <fig id="fig02" position="float">
        <label>Figure 2</label>
        <caption>
          <title>Comparison of the CRC microbial signature to IBD microbiomes</title>
          <p>
            <list list-type="alpha-upper">
              <list-item>
                <p>Ranked predictions of the metagenomic classifier (mean test prediction for study populations F, G
and H) are plotted for each individual (labels on top indicate grouping) with the percentage of
positive CRC predictions annotated in red. Proportions of true negatives (TN), false positives (FP),
false negatives (FN), and true positives (TP) are shown at the bottom for a decision boundary of
0.275 (see Fig <xref ref-type="fig" rid="fig01">1</xref>). Application of the CRC classifier to
metagenomes from ulcerative colitis (UC) and Crohn's disease (CD) patients indicates a
threefold increased false-positive rate for inflammatory bowel disease (IBD) patients, suggesting
some similarities between CRC and IBD.</p>
              </list-item>
              <list-item>
                <p>Relative abundance distributions of the four most discriminative markers for CRC classification
(see Fig <xref ref-type="fig" rid="fig01">1</xref>A) are plotted for each patient subgroup,
including UC and CD (see key). All markers showed significantly stronger association with
(enrichment in) CRC than with IBD (Wilcoxon test, UC and CD tested together; see also Supplementary
Fig S8). Boxplots are as defined in Fig <xref ref-type="fig" rid="fig01">1</xref>E.</p>
              </list-item>
            </list>
          </p>
        </caption>
        <graphic xlink:href="msb0010-0766-f2"/>
      </fig>
    </sec>
    <sec>
      <title>Fecal CRC markers reflect enrichments in tumor biopsies</title>
      <p>In order to make use of functional data extracted from the metagenome, fecal samples would need
to reflect, at least partially, the microbial composition in the tumor environment. However,
profiling colonic tissue samples with shotgun metagenomic sequencing is still ineffective due to
excessive contamination with human DNA (Castellarin <italic>et al</italic>, <xref rid="b18" ref-type="bibr">2012</xref>; Kostic <italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>).
As an alternative, targeted sequencing of prokaryotic 16S rRNA gene (16S) fragments from tumor
biopsies allows for taxonomic abundance estimation and identification of enriched microbes compared
to nearby intact mucosa. For this, we newly sequenced 48 tumor–normal tissue pairs (13 from
patients that were also part of study population G) and reanalyzed 79 such deeply sequenced pairs
from a published study with US American, Vietnamese, and Spanish patients (Kostic <italic>et
al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>) (see Supplementary Dataset S2 and
Materials and Methods). To be able to distinguish relevant differences between the microbial
communities at the tumor site and in stool from technical disparities due to different sample
processing methods, we generated a third dataset of 116 fecal samples (part of study population F,
see Supplementary Dataset S2) that were subjected to 16S amplicon sequencing. To profile the
taxonomic composition of 16S samples, we constructed operational taxonomic units (OTUs, 98%
sequence identity) from comprehensive databases of published 16S sequences (see Materials and
Methods) and mapped 16S reads against these. To facilitate comparisons across datasets, OTUs were
further matched to the marker species from the fecal metagenomic signature of study population F
(using a best-hit approach based on the respective 16S fragments, see Materials and Methods). When
comparing relative abundances between datasets (Fig <xref ref-type="fig" rid="fig03">3</xref>), both
fecal CRC marker species from the <italic>Fusobacterium</italic> genus showed a consistent
enrichment at the tumor site, as was expected from previous studies (Castellarin <italic>et
al</italic>, <xref rid="b18" ref-type="bibr">2012</xref>; Kostic <italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>; Warren <italic>et al</italic>, <xref rid="b91" ref-type="bibr">2013</xref>). Higher detection rates were observed in the tumor microenvironment compared
to feces (Fig <xref ref-type="fig" rid="fig03">3</xref>), suggesting a dilution effect that can,
however, be overcome by deep sequencing of fecal material. Despite this, most of the abundance
differences in feces between CRC patients and tumor-free controls were at least as significant as
between tumor and normal tissue in the datasets compared here. We further observed increased
abundance of the third CRC marker species, <italic>Peptostreptococcus stomatis</italic>, in CRC
consistent with biopsies, but this trend was only significant in the published dataset (Kostic
<italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>). Where comparability could be
established across sequencing technologies, most metagenomic marker species with significantly
decreased abundance in CRC patients from study population F also showed similar abundance changes in
normal tissue compared to tumor, as it was the case for <italic>Eubacterium</italic> spp. and
<italic>Streptococcus salivarius</italic> (Fig <xref ref-type="fig" rid="fig03">3</xref> and
Supplementary Fig S9A). These results indicate that similar trends for the relative abundances of
marker species between fecal and biopsy samples from CRC patients are detectable despite the
apparent differences in patient nationality, sample origin, experimental techniques, and analysis
methodology. We furthermore verified that the similarity between tumor-associated microbiota and
enrichments in fecal samples from CRC patients is not confined to the marker species only, but also
manifests as a dominant trend in principal component analysis (PCA) (Supplementary Fig S9B). All
this suggests that fecal readouts may also allow for inferences of the metabolic and functional
potential of the colonic microbiome in the tumor environment.</p>
      <fig id="fig03" position="float">
        <label>Figure 3</label>
        <caption>
          <title>Consistency of CRC marker species abundances in fecal metagenomes and 16S rRNA profiles of
tumor biopsies</title>
          <p>Horizontal bars indicate changes in median relative abundance (rel. abundance) of the CRC marker
species (as in Fig <xref ref-type="fig" rid="fig01">1</xref>A) that significantly differed between
CRC patients and tumor-free controls (excluding large adenomas; all nominal
<italic>P</italic>-values &lt; 0.005, Wilcoxon test, see also Supplementary Fig S9). These are
compared to 16S OTU abundances from a subset of fecal samples from study population F as well as to
two groups of patients in which microbial communities on tumor biopsies and healthy colonic mucosa
were profiled and compared (of the 48 patients in study population G*, 13 are part of study
population G, see also Kostic <italic>et al</italic> (<xref rid="b49" ref-type="bibr">2012</xref>)).
Boxes denote the interval between the 10<sup>th</sup> and 90<sup>th</sup> percentile of relative
abundance. Metagenomic marker species were matched to 16S OTUs using a best-hit approach for the
amplified 16S rRNA gene regions (NA, not matched, see Methods), both <italic>Fusobacterium</italic>
species were matched to the same 16S OTUs. Significance was assessed by unpaired and paired Wilcoxon
tests for fecal and biopsy datasets, respectively (*nominal <italic>P</italic>-value &lt;
0.05, **<italic>P</italic>-value &lt; 0.005,
***<italic>P</italic>-value &lt; 0.0005). Note that for the majority of the
species shown, the significance for distinguishing CRC patients from controls is higher (lower
<italic>P</italic>-value) in metagenomic than 16S readouts. Vertical bars display the prevalence
(prev.) of CRC marker species per patient/sample group (percentage of individuals in which these
species/OTUs were detected with a relative abundance exceeding 1E-5).</p>
        </caption>
        <graphic xlink:href="msb0010-0766-f3"/>
      </fig>
    </sec>
    <sec>
      <title>Functional changes in the CRC-associated fecal microbiome</title>
      <p>To characterize microbial gene functions and how these differ between CRC patients and tumor-free
participants, we quantified the relative abundances of prokaryotic KEGG (Kyoto Encyclopedia of Genes
and Genomes) modules (Kanehisa <italic>et al</italic>, <xref rid="b43" ref-type="bibr">2008</xref>)
in each metagenome of study population F (see Materials and Methods). To investigate carbohydrate
utilization preferences of the microbiota (Sonnenburg <italic>et al</italic>, <xref rid="b78" ref-type="bibr">2005</xref>; Koropatkin <italic>et al</italic>, <xref rid="b47" ref-type="bibr">2012</xref>; El Kaoutari <italic>et al</italic>, <xref rid="b27" ref-type="bibr">2013</xref>), we
additionally used prokaryotic families of carbohydrate-active enzymes from the CAZy database
(Cantarel <italic>et al</italic>, <xref rid="b14" ref-type="bibr">2009</xref>) to annotate
metagenomes (see Materials and Methods). As a result, we found 24 KEGG modules and 20 CAZy families
to significantly differ in abundance in CRC patients (Fig <xref ref-type="fig" rid="fig04">4</xref>).</p>
      <fig id="fig04" position="float">
        <label>Figure 4</label>
        <caption>
          <title>Functional changes derived from the CRC-associated metagenome</title>
          <p>
            <list list-type="alpha-upper">
              <list-item>
                <p>Significant changes in relative abundance of genes summarized by KEGG module annotations between
cancer and non-cancer metagenomes are shown for cases with a &gt; 1.33-fold change and an
FDR-adjusted <italic>P</italic>-value &lt; 0.01 (see legend and Materials and Methods). General
trends in functional potential, such as enrichment of lipopolysaccharide (LPS) metabolism, and
putrefaction in the CRC microbiome are summarized to the right of the heatmap.</p>
              </list-item>
              <list-item>
                <p>Significant relative abundance changes of genes summarized by CAZy family annotation with a
&gt; 1.33-fold change and an FDR-adjusted <italic>P</italic>-value &lt; 0.01 (see Materials
and Methods). A metabolic switch to degradation of host carbohydrates, for example, mucins, in CRC
metagenomes is annotated to the right. Moreover, a CRC-associated increase in metabolism of
potentially pro-inflammatory bacterial cell wall components, such as lipopolysaccharide (LPS), is
evident. Together with an increase of nitrate reduction in CRC metagenomes (A), this is consistent
with a bloom of Proteobacteria (see also Supplementary Figs S2 and S3).</p>
              </list-item>
            </list>
          </p>
        </caption>
        <graphic xlink:href="msb0010-0766-f4"/>
      </fig>
      <p>Analysis of the functions that significantly differed between healthy participants and cancer
patients revealed a global metabolic shift from predominant utilization of dietary fiber in the
tumor-free colon to more host-derived energy sources in CRC (Fig <xref ref-type="fig" rid="fig04">4</xref>B). In healthy gut metagenomes, exclusively some fiber-degrading enzymes and fiber-binding
domains were enriched, whereas in CRC metagenomes, the microbiota appeared to exploit growth
substrates derived from host cells to a much larger extent (fivefold enrichment of host glycans in
CRC, <italic>P</italic> = 0.01, Fisher test, Fig <xref ref-type="fig" rid="fig04">4</xref>B).
Thus, we hypothesize that an increased degradation of host glycans might be related to the etiology
of CRC. However, because dietary data are not available for our study populations, we cannot rule
out that differences in eating behavior between CRC patients and controls might contribute to the
observed trends, as the gut metagenome can be affected by diet (e.g. Claesson <italic>et
al</italic>, <xref rid="b19" ref-type="bibr">2012</xref>; David <italic>et al</italic>, <xref rid="b21" ref-type="bibr">2014</xref>; Le Chatelier <italic>et al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>; Turnbaugh <italic>et al</italic>, <xref rid="b85" ref-type="bibr">2009</xref>). Host cell wall carbohydrates, such as mucins, whose utilization is enriched in the
CRC metagenomes of study population F, have been established as an important energy source for
commensal microbiota of the healthy gut (Sonnenburg <italic>et al</italic>, <xref rid="b78" ref-type="bibr">2005</xref>; Koropatkin <italic>et al</italic>, <xref rid="b47" ref-type="bibr">2012</xref>; Bergstrom &amp; Xia, <xref rid="b10" ref-type="bibr">2013</xref>). However,
compromised integrity of the inner mucus layer that functions to shield the epithelium from luminal
bacteria might accelerate the progression of CRC and inflammatory bowel disease: In animal models,
mucin gene defects can lead to intestinal cancers or microbiota-dependent acute colitis (Velcich
<italic>et al</italic>, <xref rid="b87" ref-type="bibr">2002</xref>; Fu <italic>et al</italic>,
<xref rid="b33" ref-type="bibr">2011</xref>; Bergstrom &amp; Xia, <xref rid="b10" ref-type="bibr">2013</xref>). In IBD patients, increased mucolytic activity has been reported for mucus-associated
bacteria (Png <italic>et al</italic>, <xref rid="b66" ref-type="bibr">2010</xref>). It is therefore
conceivable that degrading the mucus barrier might be a strategy that is adopted by adhesive and/or
invasive pathogens such as <italic>Fusobacterium</italic> spp. to reach the epithelial cells
(Dharmani <italic>et al</italic>, <xref rid="b22" ref-type="bibr">2011</xref>; McGuckin <italic>et
al</italic>, <xref rid="b61" ref-type="bibr">2011</xref>; Rubinstein <italic>et al</italic>, <xref rid="b71" ref-type="bibr">2013</xref>).</p>
      <p>Some host cell-derived metabolites are more abundant in the tumor environment, for instance amino
acids, of which elevated levels have been measured in CRC patients by metabolomics (Weir <italic>et
al</italic>, <xref rid="b92" ref-type="bibr">2013</xref>). Our data showed an increased capacity of
the CRC-associated microbiota for uptake and metabolism of some amino acids via the putrefaction
pathway (Fig <xref ref-type="fig" rid="fig04">4</xref>A). The degradation products from this pathway
include polyamines (like putrescine), which at increased intracellular levels promote tumor
development (Gerner &amp; Meyskens, <xref rid="b35" ref-type="bibr">2004</xref>). It was recently
shown that enterotoxigenic <italic>Bacteroides fragilis</italic> can exploit this by stimulating the
endogenous polyamine catabolism in colonic epithelial cells (Goodwin <italic>et al</italic>, <xref rid="b37" ref-type="bibr">2011</xref>). Although our functional analysis cannot reveal whether the
observed enrichment of putrefaction in the CRC microbiome is a consequence of tumor metabolism or
whether it contributes causally to tumor progression, it provides additional evidence for the
‘oral microbiome hypothesis’ (Warren <italic>et al</italic>, <xref rid="b91" ref-type="bibr">2013</xref>): Previously, it was noted that several CRC-associated bacteria, for example,
<italic>Fusobacterium</italic> spp., were first described as oral pathogens, and it has been
hypothesized that their invasion of the gut microbiome might cause or contribute to tumorigenesis
(Warren <italic>et al</italic>, <xref rid="b91" ref-type="bibr">2013</xref>). In line with this,
<italic>Peptostreptococcus stomatis</italic> (Downes &amp; Wade, <xref rid="b23" ref-type="bibr">2006</xref>) and <italic>Porphyromonas asaccharolytica</italic>, which we found to be associated
with CRC, were also described as oral pathogens before (Park <italic>et al</italic>, <xref rid="b65" ref-type="bibr">2013</xref>). Similarly, putrescine/spermidine metabolism has been
described as a core trait of the oral microbiota (Abubucker <italic>et al</italic>, <xref rid="b1" ref-type="bibr">2012</xref>; Shafquat <italic>et al</italic>, <xref rid="b74" ref-type="bibr">2014</xref>).</p>
      <p>Concomitant with the metabolic shift in the CRC microbiome, we observed an expanded repertoire of
pro-inflammatory and pathogenicity processes, most notably an increased potential for
lipopolysaccharide (LPS) metabolism (Fig <xref ref-type="fig" rid="fig04">4</xref>), which is
consistent with a CRC-associated expansion of gram-negative bacteria that bear LPS antigens on their
outer membranes. Through binding to Toll-like receptor 4 (TLR4) in epithelial cells, LPS triggers an
inflammatory signaling cascade, which in turn could promote inflammation-induced carcinogenesis
(Cario <italic>et al</italic>, <xref rid="b17" ref-type="bibr">2000</xref>; Tang <italic>et
al</italic>, <xref rid="b82" ref-type="bibr">2010</xref>) and even metastasis, as has been
demonstrated in mice (Hsu <italic>et al</italic>, <xref rid="b39" ref-type="bibr">2011</xref>). An
enrichment of hemolysin transport, RTX toxin transport, and type II secretion systems in CRC
metagenomes hints at an increase of pathogenicity processes encoded in the genomes of gram-negative
bacteria. To examine virulence factors and secreted toxins whose potential roles in the etiology of
CRC were discussed before (Boleij &amp; Tjalsma, <xref rid="b12" ref-type="bibr">2012</xref>), we
profiled a manually curated list of 15 toxin families and virulence factors in our metagenomic data.
However, most of these (including <italic>BFT</italic> and the <italic>pks</italic> island) were
either not detectable in fecal metagenomes or not enriched in CRC patients, except for
<italic>Fusobacterium</italic> adhesin (<italic>fadA</italic>), which was recently shown to be
required for its invasiveness and tumorigenesis (Supplementary Table S2; Rubinstein <italic>et
al</italic>, <xref rid="b71" ref-type="bibr">2013</xref>; Strauss <italic>et al</italic>, <xref rid="b79" ref-type="bibr">2011</xref>).</p>
      <p>Analyzed here for the first time, the complex functional alterations in the microbiome of CRC
patients appear to occur gradually during CRC progression from precancerous stages to metastasized
carcinomas (Fig <xref ref-type="fig" rid="fig04">4</xref>). To directly assess this correlation, we
applied PCA to significantly altered KEGG modules and CAZy families (as shown in Fig <xref ref-type="fig" rid="fig04">4</xref>, using the same grouping of patients by CRC stage as above, see
Materials and Methods). Indeed, the first principal component capturing the dominant source of
functional variation between CRC patients and controls (PC1, explaining 43% of total
variance) strongly correlated with neoplasia progression (Spearman's rho &gt; 0.45,
<italic>P</italic> &lt; 1E-8, Fig <xref ref-type="fig" rid="fig05">5</xref>), indicating that
some functional changes in the microbiota are already detectable in early stages of neoplastic
growth.</p>
      <fig id="fig05" position="float">
        <label>Figure 5</label>
        <caption>
          <title>Functional changes correlate with CRC progression</title>
          <p>Principal component analysis of (log10-transformed) relative abundances of CRC-associated
functional categories (as in Fig <xref ref-type="fig" rid="fig04">4</xref>) revealed cancer
progression as a dominant source of variation (each dot corresponds to a participant of study
population F, color-coded by patient subgroup). The first principal component (PC1) accounting for
43% of the variation in CRC-associated functional changes correlated with cancer progression
(Spearman correlation of 0.45, <italic>P</italic> &lt; 1E-8) and stratified non-neoplastic,
adenoma, and early- and late-stage CRC patients (color-coded). Shown below are boxplots of each
patient's PC1 value grouped by cancer progression. Significant differences between groups
were established using pairwise Wilcoxon tests (see bottom right legend). Boxes denote interquartile
ranges (IQR) with the median as a black line and whiskers extending up to the most extreme points
within 1.5-fold IQR (see Supplementary Fig S6E for a CRC classification based on functional
features).</p>
        </caption>
        <graphic xlink:href="msb0010-0766-f5"/>
      </fig>
      <p>To explore whether also functional metagenomic profiles would be useful for CRC detection, we
applied the above-described classification framework to KEGG module and CAZy family abundance data.
Although the resulting models were less accurate (both AUCs 0.77) than the one based on marker
species (Fig <xref ref-type="fig" rid="fig01">1</xref>) and comparable to models utilizing taxonomic
abundances summarized at higher ranks (Supplementary Fig S6D), a model based on both functional and
taxonomic features yielded an improvement in accuracy over the best taxonomic model (AUC of 0.87
compared to 0.84; Supplementary Fig S6E and G).</p>
    </sec>
  </sec>
  <sec sec-type="discussion">
    <title>Discussion</title>
    <p>We have shown here that a noninvasive fecal readout allows for accurate detection of CRC in a
preclinical setting based on a multi-species predictive model derived from metagenomic data. That
both gene and species markers indicate microbiota changes already during early stages of neoplastic
growth (Figs <xref ref-type="fig" rid="fig01">1</xref>E, <xref ref-type="fig" rid="fig04">4</xref>
and <xref ref-type="fig" rid="fig05">5</xref>), suggests that identification of reliable microbial
markers for advanced adenomas as CRC precursors may be possible. Thus, future studies, ideally in
large-scale comparisons to other recently established CRC screening tools (e.g., immunochemical FOBT
and (epi-)genetic tests (Allison <italic>et al</italic>, <xref rid="b3" ref-type="bibr">2007</xref>;
Hol <italic>et al</italic>, <xref rid="b38" ref-type="bibr">2010</xref>; Imperiale <italic>et
al</italic>, <xref rid="b41" ref-type="bibr">2014</xref>)), should systematically explore this
possibility because the detection of pre-cancerous lesions with high sensitivity is still a big
challenge.</p>
    <p>Our results indicate functional and taxonomic associations with CRC and conceptually establish
the possibility of CRC detection from fecal microbial markers. Their future application in mass
screening will depend on the development of cost-effective assays. Toward this goal, we assessed
whether 16S sequencing of fecal samples would be a suitable alternative. A 16S-based classifier for
CRC detection, cross-validated on the subset of study population F for which we had also generated
16S data (<italic>N</italic> = 116), achieved almost as good an accuracy (AUC 0.82;
Supplementary Fig S10) as the models based on metagenomic community profiles (AUC 0.84–0.87;
Supplementary Fig S10). While our work was under review, another study (Zackular <italic>et
al</italic>, <xref rid="b95" ref-type="bibr">2014</xref>) independently arrived at the conclusion
that 16S sequencing of fecal samples would allow for accurate CRC screening based on classification
models that showed some overlap with our CRC markers at higher taxonomic ranks. But because these
were trained on a smaller dataset and were neither cross-validated nor validated in external
datasets, it is questionable whether the reported accuracy would be maintainable in other study
populations.</p>
    <p>While our results of 16S-based CRC detection underline the potential of microbiota for cancer
screening, for future development of economic and robust PCR-based assays, it remains to be seen how
the 16S gene compares to metagenomics-derived marker genes (Mende <italic>et al</italic>, <xref rid="b62" ref-type="bibr">2013</xref>). Moreover, additional metagenomic data will enable more
detailed investigation of cancer-associated differences in gene function, gene content, and genomic
variation (Schloissnig <italic>et al</italic>, <xref rid="b72" ref-type="bibr">2013</xref>), serving
as a starting point for proposing testable mechanistic hypotheses about the roles of microbiota in
cancer onset and progression. This might not only advance our understanding of CRC etiology, but
also help to fully realize the potential of the gut microbiome for screening, mortality reduction,
and prevention (Faivre <italic>et al</italic>, <xref rid="b28" ref-type="bibr">2004</xref>;
Assistance Publique - Hôpitaux de Paris, <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/study/NCT01270360">http://clinicaltrials.gov/ct2/show/study/NCT01270360</ext-link>).</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>Materials and Methods</title>
    <sec>
      <title>Data collection for study population F</title>
      <sec>
        <title>Patient recruitment and characterization at the Creteil Henri Mondor Hospital
(France)</title>
        <p>Participants of study population F were selected from a cohort of 648 patients recruited with
informed consent between 2004 and 2006 from different endoscopy departments at Assistance Publique -
Hôpitaux de Paris (academic hospitals) where they had been referred for colonoscopy (detailed
in Sobhani <italic>et al</italic>, <xref rid="b77" ref-type="bibr">2011</xref>). The study protocol
was approved by the Comité Consultatif de Protection des Personnes dans la Recherche
Biomédicale (CCPPRB Créteil-Henri Mondor) that authorized the enrollment of patients
in all associated centers and by the respective institutional review board (EMBL Bioethics Internal
Advisory Board) and is in agreement with the WMA Declaration of Helsinki and the Department of
Health and Human Services Belmont Report. This study population only included participants without
previous colon or rectal surgery, colorectal cancer, inflammatory or infectious injuries of the
intestine; patients with need for emergency colonoscopy were also excluded. Participants performed a
fecal occult blood test (FOBT) at home and sent them via mail to the laboratory (Le centre national
de lecture des Hémoccult, Caisse Primaire d'Assurance Maladie (CPAM), Paris) following
the standard process of FOBT mass screening in France. They also agreed to give blood for DNA
extraction and the <italic>wif-1</italic> methylation assay (as described in Mansour &amp;
Sobhani (<xref rid="b57" ref-type="bibr">2009</xref>)).</p>
      </sec>
      <sec>
        <title>Fecal sample collection</title>
        <p>Fresh stool samples were collected 2 weeks to 3 days before colonoscopy and in all cases prior to
bowel cleanse (Sobhani <italic>et al</italic>, <xref rid="b77" ref-type="bibr">2011</xref>). Whole
fresh stool was collected in sterile boxes, and 10 g was frozen at −20°C within 4 h
and deposited at the Henri Mondor Hospital biobank CRB (Biological Resources Center). 156 samples
were then selected for DNA extraction and shotgun sequencing, among them samples from 53 patients
with CRC, 42 adenoma patients, and 61 randomly chosen controls. Colonic neoplasia status was
determined by colonoscopy (Table <xref ref-type="table" rid="tbl1">1</xref>, Supplementary Table S1
and Supplementary Dataset S1 for participant metadata). For a subset of 129 patients, 16S rDNA could
be amplified from the same DNA extracts and subjected to 16S amplicon sequencing (see below and
Supplementary Dataset S2).</p>
      </sec>
    </sec>
    <sec>
      <title>Data collection for study population G</title>
      <sec>
        <title>Patient recruitment at the University Hospital Heidelberg (Germany)</title>
        <p>38 colorectal cancer patients without a medical history of inflammatory disease were selected
from the ColoCare Study (study population G) (see Supplementary Table S1 and Supplementary Dataset
S1 for patient metadata). ColoCare is an international prospective cohort study recruiting newly
diagnosed colorectal cancer patients prior to surgery in Germany and the USA. Recruitment sites in
Heidelberg are the Department of Surgery at the University Hospital Heidelberg and the affiliated
Hospital Salem. Written informed consent was obtained from all study participants. The study
protocol was approved by the ethics committee of the Medical Faculty at the University of Heidelberg
and by the respective institutional review board (EMBL Bioethics Internal Advisory Board) and is in
agreement with the WMA Declaration of Helsinki and the Department of Health and Human Services
Belmont Report.</p>
      </sec>
      <sec>
        <title>Fecal sample collection</title>
        <p>Fecal samples were collected between diagnosis of colorectal cancer and surgery at least 10 days
after bowel cleanse and colonoscopy. Stool samples were stored in RNAlater® Solution
(Sigma-Aldrich) and frozen at −80°C upon arrival in the laboratory.</p>
      </sec>
    </sec>
    <sec>
      <title>Data collection for study population H</title>
      <sec>
        <title>Fecal sample collection from healthy German participants</title>
        <p>Informed consent was obtained from five healthy individuals living in Germany through the
my.microbes project (<ext-link ext-link-type="uri" xlink:href="http://my.microbes.eu">http://my.microbes.eu</ext-link>) to obtain samples as additional
controls. The study protocol was approved by the respective institutional review board (EMBL
Bioethics Internal Advisory Board) and is in agreement with the WMA Declaration of Helsinki and the
Department of Health and Human Services Belmont Report. Fecal samples were collected and conserved
under anaerobic conditions in a sealed bag, kept at −20°C for short-term storage, and
stored at −80°C upon arrival in the laboratory (see Supplementary Table S1 and
Supplementary Dataset S1 for participant metadata).</p>
      </sec>
      <sec>
        <title>Inclusion of published fecal metagenomes</title>
        <p>Samples from Danish and Spanish individuals not diagnosed with colorectal cancer were included in
study population H as additional controls (Qin <italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>; Le Chatelier <italic>et al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>). Because they did not undergo colonoscopy, we cannot rule out the possibility that
some of them have adenomas or carcinomas, but this is expected to only lead to a slight
(conservative) overestimation of false-positive CRC predictions in study population H.</p>
      </sec>
      <sec>
        <title>Fecal metagenomic data from IBD patients</title>
        <p>In addition to study population H, we investigated 25 published fecal metagenomes of patients
with an inflammatory bowel disease (IBD) (Qin <italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>) (see Fig <xref ref-type="fig" rid="fig02">2</xref>), but these were not used
as controls for CRC classification in study population H (see Supplementary Dataset S1 for
participant metadata).</p>
      </sec>
    </sec>
    <sec>
      <title>Data collection for 16S rRNA gene sequencing from colonic tissue</title>
      <sec>
        <title>Patient recruitment at the University Hospital Heidelberg (Germany)</title>
        <p>Colonic tissue was collected from 48 patients undergoing colorectal cancer surgery at the
Department of Surgery, University Hospital Heidelberg after obtaining informed consent. Written
consent procedure and the study protocol were approved by the ethics committee of the Medical
Faculty at the University of Heidelberg (see Supplementary Dataset S2 for participant metadata).</p>
      </sec>
      <sec>
        <title>Tissue samples for 16S rRNA gene sequencing</title>
        <p>Matched tissue samples (tumor and nearby morphologically healthy mucosa) were collected from
these 48 patients within ∼30 min after surgical resection, immediately snap-frozen, and
stored at −80°C until DNA extraction and 16S rRNA gene sequencing. Of the 48 patients
(study population G*), 13 patients also participated in the ColoCare study (study population
G) and we not only obtained tissue samples, but also fecal samples in RNALater (Supplementary
Dataset S2).</p>
      </sec>
      <sec>
        <title>DNA extraction from stool and tissue samples</title>
        <p>Genomic DNA was extracted from frozen or RNAlater-preserved fecal samples as previously described
(Furet <italic>et al</italic>, <xref rid="b34" ref-type="bibr">2009</xref>) using the GNOME®
DNA Isolation Kit (MP Biomedicals) with the following minor modifications: cell lysis/denaturation
was performed (30 min, 55°C) before protease digestion was carried out overnight
(55°C), and RNAse digestion (50 μl, 30 min, 55°C) was performed after
mechanical lysis. Tissue samples were thawed carefully, cleaned from remaining feces with sterile
Dulbecco's PBS (PAA Laboratories) if necessary, and the blades were cleaned with
Incidin® Plus (Ecolab) between samples. DNA was extracted from the tissue surfaces using the
protocol above. After final precipitation, the DNA was resuspended in TE buffer and stored at
−20°C for further analysis.</p>
      </sec>
    </sec>
    <sec>
      <title>Sequencing and quality control</title>
      <sec>
        <title>Library preparation for metagenomic sequencing</title>
        <p>Library preparation was automated and adapted on a Biomek FXp Dual Hybrid, with high-density
layout adaptors, orbital shaker, static peltier, shaking peltier (Beckman Coulter, Brea, USA), and a
robotic PCR cycler (Biometra, Göttingen, Germany). Magnetic beads were separated on a 96-ring
magnet. PCRs were performed in full-skirted plates and sealed with arched auto-sealing lids (Bio
Rad, Hercules, USA). Library quality was analyzed on a Fragment Analyzer (Advanced Analytics
Technologies, Ames, USA). One-milliliter 96-well microtiter plates were used as cooling reservoirs
for stock solutions containing the enzymes. Bead processing was performed in Abgene 1.2-ml square
well u-bottomed plates (Thermo Scientific, Waltham, USA).</p>
        <p>Sequencing libraries were generated with SPRIworks HT chemicals (Beckman Coulter) according to
the supplier's recommendation with the following modifications: 150 ng DNA starting amount,
adaptor dilution 1:25, kit chemical dilution 1:1 in process. Purification steps until PCR were
performed according to the protocol (Fisher <italic>et al</italic>, <xref rid="b31" ref-type="bibr">2011</xref>). Using a double size selection we enriched for 250 base fragments, subsequently beads
were washed twice with 70% ethanol, and process mixing was performed on the orbital shaker.
All additions of reactants were done with span 8 head and sample processing with the 96 tip head.
Dead volume and pipetting profile corrections were set with respect to the tip types and solutions
used.</p>
      </sec>
      <sec>
        <title>Metagenomic sequencing</title>
        <p>Whole-genome shotgun sequencing of fecal samples collected in France and Germany was carried out
on the Illumina HiSeq 2000/2500 (Illumina, San Diego, USA) platform. All samples were paired-end
sequenced with 100-bp read length at the Genomics Core Facility, European Molecular Biology
Laboratory, Heidelberg, to a targeted sequencing depth of 5 Gbp (see Supplementary Dataset S1 for
sequencing results).</p>
      </sec>
    </sec>
    <sec>
      <title>16S rRNA gene sequencing</title>
      <p>DNA from 48 tissue sample pairs (tumor and healthy mucosa) and 129 fecal samples (which are a
subset of study population F) was amplified using primers targeting the V4 region of the 16S rRNA
gene (F515 5′-GTGCCAGCMGCCGCGGTAA-3′, R806 5′-GGACTACHVGGGTWTCTAAT-3′)
(Caporaso <italic>et al</italic>, <xref rid="b16" ref-type="bibr">2011</xref>). PCR was carried out
according to the manufacturer's instructions of the Q5 high-fidelity polymerase (New England
BioLabs, Ipswich, USA) using bar-coded primers (NEXTflex™ 16S V4 Amplicon-Seq Kit, Bioo
Scientific, Austin, Texas, USA) at final concentrations of 0.2 μM and an annealing
temperature of 56°C for 35 cycles.</p>
      <p>PCR products were cleaned up with Agencourt AMPure XP-PCR Purification system (Beckman Coulter,
Brea, USA), quantified according to the NEXTflex™ 16S V4 Amplicon-Seq Kit protocol, and
multiplexed at equal concentration. Sequencing was performed using a 250-bp paired-end sequencing
protocol on the Illumina MiSeq platform (Illumina, San Diego, USA) at the Genomics Core Facility,
European Molecular Biology Laboratory, Heidelberg.</p>
    </sec>
    <sec>
      <title>Data analysis</title>
      <sec>
        <title>Taxonomic profiling of fecal samples</title>
        <p>Using MOCAT (option <italic>screen</italic> with alignment length cutoff 45 and minimum
97% sequence identity), taxonomic relative abundance profiles were generated by mapping
screened high-quality reads (see below for details) from each metagenome to a database consisting of
10 universal single-copy marker genes extracted from 3,496 NCBI reference genomes (Mende <italic>et
al</italic>, <xref rid="b62" ref-type="bibr">2013</xref>; Sunagawa <italic>et al</italic>, <xref rid="b80" ref-type="bibr">2013</xref>). Quantification proceeded in two steps, by first estimating
taxonomic abundances from all sequenced DNA fragments (nucleotide counts; each read contributing
number of counts equal to its length) that mapped uniquely, and in a second step, nucleotide counts
from reads mapping to multiple taxa with the same alignment score were distributed among them
proportionally to nucleotide counts originating from reads uniquely mapped to these taxa. Finally,
base counts were gene length-normalized (option profiling). Abundance estimates at species level
were made based on a recently proposed consistent species-level clustering (Mende <italic>et
al</italic>, <xref rid="b62" ref-type="bibr">2013</xref>), while abundance summarization at higher
taxonomic levels was based on the NCBI Taxonomy (Supplementary Figs S2 and S3).</p>
      </sec>
      <sec>
        <title>Taxonomic profiling of tissue and fecal samples using 16S rRNA gene sequences</title>
        <p>Raw sequencing data were quality-controlled as described below for the generation of the
metagenomic gene catalog (minimum read length = 45 bp; minimum base quality score =
20). Paired-end reads were merged using the SeqPrep software (<ext-link ext-link-type="uri" xlink:href="https://github.com/jstjohn/SeqPrep">https://github.com/jstjohn/SeqPrep</ext-link>) requiring perfect overlap between the high-quality
paired-end reads.</p>
        <p>After excluding reads shorter than 200 nt or with more than five ambiguous bases, we aligned them
to the SILVA 16S reference database of bacterial and archaeal 16S rRNA sequences. These alignments
were cropped to only retain the region spanning V3 to V4 using mothur, version 1.30.2 (Schloss
<italic>et al</italic>, <xref rid="b73" ref-type="bibr">2009</xref>). With the same screening and
alignment routines, we reanalyzed 16S rRNA sequencing reads from Kostic <italic>et al</italic>
(<xref rid="b49" ref-type="bibr">2012</xref>) to facilitate comparisons across datasets. For further
analysis, we only retained sample pairs with at least 1,000 reads aligned in the tumor as well as
the normal tissue sample (a requirement met by 79 sample pairs from Kostic <italic>et al</italic>
(<xref rid="b49" ref-type="bibr">2012</xref>)). The boundaries of this core alignment were adjusted
to accommodate both the pyrosequencing reads from (Kostic <italic>et al</italic>, <xref rid="b49" ref-type="bibr">2012</xref>) and ours from the MiSeq platform, by first separately
determining the region spanned by 90% of the reads from each sequencing platform and second
by interval merging to cover both of these regions.</p>
        <p>For high-resolution taxonomic profiling, we built OTUs from large collections of published 16S
rRNA genes. We included 436,028 sequences from the SILVA database (version 115 (Pruesse <italic>et
al</italic>, <xref rid="b67" ref-type="bibr">2007</xref>)) and 5,224 extracted from the prokaryotic
genome sequences used for taxonomic profiling of metagenomic reads (see above). These were aligned
with the same protocol as the 16S reads and cropped to the core alignment region using mothur.
Subsequently, we removed redundancy by dereplication (mothur's unique.seqs) and clustering at
98% sequence identity using UCLUST (version 6.0.307 with the option -maxrejects 1000 for more
accurate matching) (Edgar, <xref rid="b26" ref-type="bibr">2010</xref>). As an initial
quantification and ordering for the heuristic UCLUST algorithm, we mapped 10,000 reads from each
sample against the reference sequences and sorted them according to the number of mapped reads using
USEARCH routines (98% ID, best-hit).</p>
        <p>After we had clustered reference sequences into 2,460 OTUs (with a minimum size of 10), we mapped
all 16S Illumina and pyrosequencing reads against these taking a best-hit approach with a minimum of
98% sequence identity between matches (using USEARCH with default settings).</p>
      </sec>
      <sec>
        <title>Generation of the metagenomic gene catalog</title>
        <p>Raw paired-end Illumina FastQ files from metagenomic samples were processed using MOCAT (version
1.2) (Kultima <italic>et al</italic>, <xref rid="b50" ref-type="bibr">2012</xref>), by first
removing low-quality reads (option <italic>read_trim_filter</italic> with length cutoff 45 and
quality cutoff 20). Retained high-quality (HQ) reads were screened against a custom-made fasta file
containing Illumina adapters (option <italic>screen_fastafile</italic> with e-value 0.00001 using
USEARCH (Edgar, <xref rid="b26" ref-type="bibr">2010</xref>) version 5). Adapter-screened reads were
screened against the human genome version 19 (option <italic>screen</italic> with alignment length
cutoff 45 and minimum 90% sequence identity). Screened HQ reads were assembled (option
<italic>assembly</italic> with SOAP (version 1.06) (Li <italic>et al</italic>, <xref rid="b54" ref-type="bibr">2008</xref>) and minimum length 500) and the assemblies revised (option
<italic>assembly_revision</italic> with minimum length 500). Genes were predicted on the revised
scaftigs (option <italic>gene_prediction</italic> using <italic>MetaGeneMark</italic> (Zhu
<italic>et al</italic>, <xref rid="b97" ref-type="bibr">2010</xref>) version 2.8).</p>
        <p>To obtain a comprehensive metagenomic gene catalog of the human gut microbiome, the predicted
genes from this study were pooled with predicted genes from other published human metagenome studies
(Qin <italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>, <xref rid="b69" ref-type="bibr">2012</xref>; Human Microbiome Project Consortium, <xref rid="b40" ref-type="bibr">2012</xref>) and clustered at 95% sequence identity using CD-HIT (Li &amp; Godzik, <xref rid="b55" ref-type="bibr">2006</xref>) (version 4.6.1) (parameters: -c 0.95, -M 0, -G 0 -aS 0.9, -g
1, -r 1, -d 0). The representative genes of each cluster were selected and extended up to 100 bp
(‘padded region’) at each end of the gene by using the sequence information from the
assembled scaftigs (Sunagawa <italic>et al</italic>, <xref rid="b80" ref-type="bibr">2013</xref>).</p>
      </sec>
      <sec>
        <title>Functional annotation of the metagenomic gene catalog</title>
        <p>The metagenomic gene catalog was annotated by aligning the translated amino acid sequence of each
gene to the KEGG (Kanehisa <italic>et al</italic>, <xref rid="b43" ref-type="bibr">2008</xref>)
(version 62) ortholog database using BLAST (Altschul <italic>et al</italic>, <xref rid="b4" ref-type="bibr">1990</xref>) (version 2.2.24) (max. e-value 0.01) and then annotating the genes using
SmashCommunity (Arumugam <italic>et al</italic>, <xref rid="b6" ref-type="bibr">2010</xref>)
(version 1.6). CAZy (Cantarel <italic>et al</italic>, <xref rid="b14" ref-type="bibr">2009</xref>)
annotations were made using the dbCAN pipeline (Yin <italic>et al</italic>, <xref rid="b94" ref-type="bibr">2012</xref>) with the recommended default settings; additional substrate information for
CAZy families was obtained from CAZypedia (<ext-link ext-link-type="uri" xlink:href="http://www.cazypedia.org/index.php?title=Carbohydrate-binding_modules&amp;oldid=9411">http://www.cazypedia.org/index.php?title=Carbohydrate-binding_modules&amp;oldid=9411</ext-link>,
assessed 28 October 2013) and from Cantarel <italic>et al</italic> (<xref rid="b15" ref-type="bibr">2012</xref>).</p>
      </sec>
      <sec>
        <title>Functional profiling</title>
        <p>Gene abundance profiles were calculated using MOCAT (Kultima <italic>et al</italic>, <xref rid="b50" ref-type="bibr">2012</xref>) by first mapping screened HQ reads from each metagenome to
the metagenomic gene catalog (option <italic>screen</italic> with alignment length cutoff 45 and
minimum 95% sequence identity). Each gene's abundance was estimated as gene
length-normalized nucleotide counts of all reads that matched the protein-coding region of this
gene. For each functional feature, its abundance in the metagenomic gene pool was estimated as the
sum of the relative abundances of all genes belonging to this family (Fig <xref ref-type="fig" rid="fig04">4</xref>).</p>
      </sec>
      <sec>
        <title>Relative abundance transformations and abundance filtering</title>
        <p>For all subsequent analyses, read counts were transformed into relative abundances (by dividing
through the total number of reads per sample, including high-quality reads that could not be mapped
to reference databases or annotated).</p>
        <p>For display purposes and fold change calculations, we applied a logarithmic transformation to
relative abundances using the function log<sub>10</sub>(<italic>x</italic> +
<italic>x</italic><sub>0</sub>), where <italic>x</italic> are the original relative abundances and
<italic>x</italic><sub>0</sub> a small constant (1E-6 for taxonomic and 1E-8 for functional
features).</p>
        <p>As an unsupervised feature reduction technique (that is independent of any participant metadata),
we applied a low-abundance filter, which discarded functional and taxonomic features whose relative
abundance did not exceed 0.0001 and 0.001, respectively, in any sample (for combined taxonomic and
functional features, we used an abundance cutoff of 0.0001).</p>
      </sec>
      <sec>
        <title>Analysis of diversity and community structure</title>
        <p>Species abundances (using the species delineation from Mende <italic>et al</italic> (<xref rid="b62" ref-type="bibr">2013</xref>)) were used to calculate Shannon diversity index and species
richness for each sample in study population F using the <italic>diversity</italic> and
<italic>specnumber</italic> functions, respectively, of the vegan R package (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/vegan/index.html">http://cran.r-project.org/web/packages/vegan/index.html</ext-link>). Differences between tumor-free
and CRC patients were assessed by the Kruskal–Wallis test (Supplementary Fig S1D and E).</p>
        <p>Gene richness (the number of genes from the metagenomic gene catalog with nonzero abundance) was
calculated for each sample from study population F after rarefying to 3 million reads per sample;
differences were evaluated using the Kruskal–Wallis test (Supplementary Fig S1F).</p>
        <p>As an additional high-level descriptor of gut microbial community composition, we analyzed the
abundance ratio between the phyla of Bacteroidetes and Firmicutes (Turnbaugh <italic>et al</italic>,
<xref rid="b86" ref-type="bibr">2006</xref>) with respect to separation of the three groups of
participants using the Kruskal–Wallis test (Supplementary Fig S1C).</p>
        <p>Enterotypes were determined on a reference set of the 292 healthy individuals from study
population H (Qin <italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>; Le Chatelier
<italic>et al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>) using the original
computational protocol and PCoA visualization (Supplementary Fig S1A) (for details, see Arumugam
<italic>et al</italic> (<xref rid="b8" ref-type="bibr">2014</xref>, <xref rid="b7" ref-type="bibr">2011</xref>)). We projected the 156 samples from study population F into this PCoA space (Trosset
&amp; Priebe, <xref rid="b84" ref-type="bibr">2006</xref>) and assigned enterotypes by minimal
JSD distance to the medoid of each enterotype (i.e., to the nearest cluster center). Differences in
enterotype composition between CRC patients (all stages) and tumor-free controls (some with
adenomas) of study population F were assessed using the Fisher test (Supplementary Fig S1B).</p>
        <p>Additionally, we subjected study population F to a PCoA independently of other datasets and
investigated the separation of CRC cases from controls (neoplasia-free participants and patients
with small adenomas) along principal coordinates; significance was assessed using the Wilcoxon test
(Supplementary Fig S1G–J).</p>
        <p>To assess whether differences in such high-level descriptors of microbial community structure are
useful for CRC detection, we built a logistic regression model with the ten first principal
coordinates (from Supplementary Fig S1G) and the Bacteroidetes to Firmicutes ratio (Supplementary
Fig S1C) as predictors. Its accuracy was determined using tenfold cross-validation on study
population F and ROC analysis (Supplementary Fig S1K).</p>
      </sec>
      <sec>
        <title>Confounder assessment</title>
        <p>We assessed differences in patient metadata, such as age, gender, and body mass index (BMI), as
well as in sequencing depth between CRC cases and tumor-free controls using the Wilcoxon test. While
patient age significantly differed between groups, the other variables assessed are unlikely to
confound our analyses (Supplementary Fig S5A–D). To determine how predictive the age bias and
other variations in patient characteristics are of CRC in our study populations, we built a logistic
regression model with patient gender, age, and BMI as predictors. Its accuracy was assessed in
tenfold cross-validation on study population F and in external validation on study populations G and
H and compared to the metagenomic model with significance assessed using one-sided DeLong tests (see
below and Supplementary Fig S5E). See also below for robustness analysis of the metagenomic
classifier against age bias.</p>
      </sec>
      <sec>
        <title>Statistical analysis of differentially abundant taxa and gene functions</title>
        <p>To detect significant differences in relative abundances of metagenomic features, we applied the
nonparametric Wilcoxon test (or the Kruskal–Wallis test which is its generalization to
&gt; 2 groups) as it makes only minimal assumptions about data distributions, which are not well
understood for metagenomic data.</p>
        <p>We applied this test to compare taxonomic abundance profiles (after abundance filtering, see
above) between CRC patients (all stages) adenoma patients and neoplasia-free participants. After
false discovery rate correction, features with an adjusted <italic>P</italic>-value &lt; 0.1
were deemed significant (see Supplementary Fig S2).</p>
        <p>We additionally compared taxonomic abundances between CRC patients and a control group consisting
of neoplasia-free participants and patients with small adenomas using the same approach
(Supplementary Fig S3).</p>
        <p>For functional analysis, we only included features with an adjusted <italic>P</italic>-value
&lt; 0.01 and additionally applied a minimum absolute fold change criterion (&gt; 1.33) to
focus on larger, likely more biologically meaningful effects (Fig <xref ref-type="fig" rid="fig04">4</xref>). Here, fold change was defined as the difference between groupwise medians of
log-transformed relative abundances (Fig <xref ref-type="fig" rid="fig04">4</xref>).</p>
      </sec>
      <sec>
        <title>Statistical modeling and marker extraction</title>
        <p>To distinguish CRC patients from tumor-free controls based on the taxonomic composition of their
fecal metagenomes by means of a classifier that extracts the most discriminative features (microbial
markers) and to obtain an unbiased measure of its accuracy, we developed a custom pipeline in R
(<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">http://www.R-project.org</ext-link>, version 2.12.0). Here, we
used the LASSO logistic regression classifier (Tibshirani, <xref rid="b83" ref-type="bibr">1996</xref>) implemented in LIBLINEAR (Fan <italic>et al</italic>, <xref rid="b29" ref-type="bibr">2008</xref>), because it generates a parsimonious classification model, which selects only few
features out of a potentially very large set, and because model interpretation and marker extraction
is easy due to its linearity, an advantage over, for example, random forests (c.f. Knights
<italic>et al</italic>, <xref rid="b45" ref-type="bibr">2011</xref>; Papa <italic>et al</italic>,
<xref rid="b64" ref-type="bibr">2012</xref>). Since the feature selection process is built into the
LASSO classifier, it is straightforward to obtain not only a parsimonious model, but also a
realistic estimate of its generalization error in cross-validation (avoiding a common mistake of
dubious two-stage approaches, where supervised feature selection is done before, and independent of,
cross-validation, which can lead to dramatically overoptimistic accuracy estimates (see e.g.,
Smialowski <italic>et al</italic>, <xref rid="b76" ref-type="bibr">2010</xref>).</p>
        <p>Our pipeline proceeds as follows:</p>
        <list list-type="alpha-upper">
          <list-item>
            <p>Unsupervised feature abundance filtering to remove extremely low abundant taxa (see above).</p>
          </list-item>
          <list-item>
            <p>Feature transformation: We applied the above-described log-transform and subsequently
standardized features (by centering to mean 0 and dividing by each features standard deviation to
which we added the 10<sup>th</sup> percentile of standard deviations across all features).</p>
          </list-item>
          <list-item>
            <p>Partitioning data for tenfold stratified cross-validation (we resampled dataset partitions ten
times to obtain more stable accuracy estimates).</p>
          </list-item>
          <list-item>
            <p>Fitting a LASSO model on the training data of each cross-validation fold: The LASSO
hyperparameter was optimized for each model in a nested fivefold cross-validation on the training
subset using the area under the precision–recall curve as model selection criterion and also
enforcing at least five nonzero coefficients. To obtain high-precision models, we reweighted
examples by assigning the controls five times as much weight as the cases.</p>
          </list-item>
          <list-item>
            <p>Application of the trained LASSO models to obtain the corresponding cross-validation test
predictions (Fig <xref ref-type="fig" rid="fig01">1</xref>A shows mean predictions from the ten
respective test subsets of each sample). Due to the resampled cross-validation (and also in external
validation), there are several test predictions for each test examples. To get a single prediction
score per example (e.g., as shown in Fig <xref ref-type="fig" rid="fig01">1</xref>A and D and Fig
<xref ref-type="fig" rid="fig02">2</xref>A), we averaged all test predictions (from ten or 100
models in cross-validation or external validation, respectively).</p>
          </list-item>
          <list-item>
            <p>Model evaluation using ROC analysis: From ten times resampled tenfold cross-validation, we
obtained mean test prediction scores, which we subjected to ROC analysis (see Fig <xref ref-type="fig" rid="fig01">1</xref>B and C).</p>
          </list-item>
          <list-item>
            <p>Model interpretation and marker extraction: Features (bacterial species) with potential as CRC
biomarkers were extracted as nonzero coefficients from all 100 LASSO models (trained in ten times
resampled tenfold cross-validation). Fig <xref ref-type="fig" rid="fig01">1</xref>A displays all
features that have a nonzero coefficient in at least 50% of the LASSO models in the order of
their mean percentage of total absolute coefficient weight across all models. Bar lengths in Fig
<xref ref-type="fig" rid="fig01">1</xref>A directly correspond to mean log-odds ratios across LASSO
models.</p>
          </list-item>
        </list>
        <p>This procedure was used to train and cross-validate the CRC classifier on study population F (Fig
<xref ref-type="fig" rid="fig01">1</xref>B) with patients grouped into CRC cases (all stages) and
tumor-free controls (including patients with small, but not large adenomas) as label.</p>
        <p>A second classifier was trained on the combined study populations F and G (Supplementary Fig
S6C), resulting in a more comprehensive and accurate model (see Supplementary Fig S5G for markers
present in both models). As a combination test with the FOBT, we trained a third classifier (on
study population F) which did not only use microbial species abundance features but also the FOBT
results (standardized 0/1 values) as an additional predictor (see Fig <xref ref-type="fig" rid="fig01">1</xref>B; Supplementary Fig S5G for accuracy and feature overlap with the metagenomic
classifier).</p>
        <p>To assess the effect of taxonomic resolution on CRC detection accuracy in study population F, we
reran the described classification pipeline for taxonomic abundance profiles summarized at the genus
and phylum level (Supplementary Fig S6D).</p>
        <p>Similarly, the predictivity of functional metagenomic features (relative abundances of KEGG
modules and CAZy gene families for study population F) was assessed using the same modeling pipeline
(Supplementary Fig S6E). Finally, we also built and cross-validated such a model based on a
combination of species, KEGG modules and CAZy families as input features on study population F
(Supplementary Fig S6E and G).</p>
        <p>To explore the effect of sequencing method on the ability to detect CRC, we also applied the
classification pipeline to 16S OTU abundance profiles from the subset of study population F for
which we had obtained fecal 16S sequencing data (41 CRC cases and 75 controls with small adenomas or
without any neoplasia; Supplementary Fig S10).</p>
      </sec>
      <sec>
        <title>External model validation, model comparison and confounder analysis</title>
        <p>Independent (holdout/external) validation consisted of two steps: (1) application of the feature
filtering and normalization using the same parameters as for cross-validation data (i.e., discarding
features according to the cross-validation low-abundance filter and applying the log-standardization
with mean and standard deviation values as estimated in cross-validation, see above) and (2)
application of the trained LASSO models to make predictions on the validation data.</p>
        <p>As an independent validation of the metagenomic CRC classifier, we applied the models trained on
study population F to study population G and H (fitted in cross-validation, see above). From their
mean test prediction scores, we determined the ROC curve (Fig <xref ref-type="fig" rid="fig01">1</xref>C). Additionally, we assessed its sensitivity and specificity separately on study
populations G and H, respectively (see Supplementary Fig S6A and B).</p>
        <p>Confidence intervals for ROC curves (Fig <xref ref-type="fig" rid="fig01">1</xref>B and C) were
calculated using the pROC R package (Robin <italic>et al</italic>, <xref rid="b70" ref-type="bibr">2011</xref>). Statistical significance of differences in ROC curves was also assessed using the
<italic>roc.test(…, method=‘delong’)</italic> from this package (Fig
<xref ref-type="fig" rid="fig01">1</xref>B, Supplementary Figs S5E, S6D and E). The significance of
differences in TPR at the same FPR cutoff was determined using the bootstrapping subroutine from the
same function (Fig <xref ref-type="fig" rid="fig01">1</xref>B).</p>
        <p>To rule out that the metagenomic CRC classifier exploits patient age (or BMI) as an indirect
predictor of CRC in study population F (in which CRC patients are on average older than controls,
see Supplementary Fig S5B), we assessed whether its prediction scores were biased. In case the
classifier was confounded by age, one would expect higher prediction scores for samples from older
participants. However, we could neither observe an enrichment of old participants among
false-positive predictions compared to true negatives, nor among true positives compared to false
negatives in any of the study populations F, G, and H (Supplementary Fig S5F). Note that the latter
two were not included in the classifier's cross-validation set. Likewise, we ruled out
potential confounding by BMI (Supplementary Fig S5G).</p>
      </sec>
      <sec>
        <title>Comparison between fecal metagenomes and 16S biopsy samples</title>
        <p>To establish correspondence between species profiled in fecal metagenomes and OTUs of the 16S
rRNA genes from fecal and tissue samples, we first collected genomic 16S rRNA genes for the
metagenomic CRC marker species. For each marker species, fragments of the 16S genes corresponding to
the 16S read alignments were then extracted and compared to the 16S OTUs using USEARCH (Edgar, <xref rid="b26" ref-type="bibr">2010</xref>) to find the best-matching OTUs within ≥ 97%
sequence identity (Note that this approach did not yield a match for marker species for which we
could not identify a genomic 16S sequence, or whose 16S gene fragments were too dissimilar from OTU
centroids, i.e., more than 3% diverged). The relative abundance and prevalence (defined here
as the proportion of samples in which the relative abundance of a species or OTU exceeded 1E-5) of
these OTUs in fecal, tumor, and normal tissue samples was then compared to the relative abundance
and prevalence of the corresponding metagenomic fecal marker species in CRC patients and tumor-free
controls (Fig <xref ref-type="fig" rid="fig03">3</xref>, Supplementary Fig S9A).</p>
        <p>To more globally assess similarities between microbiota at the tumor relative to nearby normal
tissue and fecal taxonomic profiles of CRC patients relative to those of tumor-free controls, we
compared microbial composition at the genus level. For 16S samples, the genus identity of each OTU
was inferred using the RDP classifier (Wang <italic>et al</italic>, <xref rid="b90" ref-type="bibr">2007</xref>), while for metagenomic stool samples, a reference-based approach was taken (see above)
(Kultima <italic>et al</italic>, <xref rid="b50" ref-type="bibr">2012</xref>). Genera (after
low-abundance filtering, see above) with significant differential abundance between tumor and normal
tissue or CRC patients and controls (FDR-corrected <italic>P</italic> &lt; 0.1 and abundance
fold change &gt; 5) were determined separately for each datasets (141 fecal metagenomics samples
from study population F, 116 fecal 16S samples, which are part of study population F, 48 16S biopsy
sample pairs from this study, and 79 16S biopsy sample pairs from Kostic <italic>et al</italic>
(<xref rid="b49" ref-type="bibr">2012</xref>); see Table <xref ref-type="table" rid="tbl1">1</xref>,
Supplementary Table S1 and Supplementary Dataset S1) using unpaired and paired Wilcoxon tests for
fecal samples and tumor–normal tissue pairs, respectively. Based on the log-transformed
relative abundances of the union set of differentially abundant genera from any of the datasets, we
conducted a joint PCA of all samples (Supplementary Fig S9B). Although sample origin and technical
differences between 16S and shotgun metagenomic sequencing were detectable in this PCA, it revealed
a separation between tumor and control samples along the first principal component that was common
to all the datasets analyzed (Supplementary Fig S9B).</p>
      </sec>
      <sec>
        <title>Cancer progression analysis using PCA of CRC-associated functional features</title>
        <p>To reveal dominant trends in functional alterations between CRC patients and tumor-free
participants of study population F, we carried out PCA using as input the relative abundances of
significantly changing functional features (Fig <xref ref-type="fig" rid="fig05">5</xref>).
Correlation between the first principal component (PC1) and cancer progression encoded as four
ordered groups of participants with: (1) no neoplasia, (2) adenoma(s), (3) CRC of AJCC stage 0 to
II, and (4) CRC of stage III and IV was established by Spearman's rank correlation test and
significant differences of PC1 values between these groups by pairwise Wilcoxon tests (Fig <xref ref-type="fig" rid="fig05">5</xref>).</p>
      </sec>
      <sec>
        <title>Targeted analysis of cancer-related gene functions and toxins</title>
        <p>To explore whether genes encoding known bacterial toxins might be enriched in the metagenomes
from CRC patients, we collected protein sequences of toxins that have previously been implicated in
intestinal diseases, mainly colorectal cancer, from the literature (Fasano, <xref rid="b30" ref-type="bibr">2002</xref>; Dutilh <italic>et al</italic>, <xref rid="b24" ref-type="bibr">2013</xref>).
With these, we performed BLAST (Altschul <italic>et al</italic>, <xref rid="b4" ref-type="bibr">1990</xref>) searches against NCBI nr as well as an in-house database of 3,496 high-quality
bacterial reference genome sequences and manually selected additional bona fide members for each
toxin gene family. Subsequently, we aligned the sequences from each toxin family using Clustal Omega
(Sievers <italic>et al</italic>, <xref rid="b75" ref-type="bibr">2011</xref>) and built HMM sequence
profiles from these alignments using HMMer 3.0 (Eddy, <xref rid="b25" ref-type="bibr">2011</xref>).
E-value cutoffs for HMM prediction were optimized on protein sequences from the in-house database of
reference genomes. Afterward we searched the metagenomic gene catalog (see above) with the profile
HMM for each toxin and quantified the abundance of matching sequences in participants of study
population F (using the above-described MOCAT routines). Statistical significance was established
using the Wilcoxon test (Supplementary Table S2).</p>
      </sec>
    </sec>
    <sec>
      <title>Data availability</title>
      <p>The shotgun metagenomic sequencing data and the 16S rRNA amplicon sequencing data from this study
are available from the European Nucleotide Archive (ENA) database (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena">http://www.ebi.ac.uk/ena</ext-link>): accession number ERP005534. Taxonomic abundance profiles
derived from metagenomics data are provided as Supplementary Dataset S3.</p>
      <p>Published metagenomics datasets analyzed here are available from ENA: accession number ERA000116
(Qin <italic>et al</italic>, <xref rid="b68" ref-type="bibr">2010</xref>) and ERP003612 (Le
Chatelier <italic>et al</italic>, <xref rid="b51" ref-type="bibr">2013</xref>). Patient data are
provided in Supplementary Datasets S1 and S2.</p>
    </sec>
  </sec>
</body>
<back>
  <ack>
    <p>We are thankful to Wolfgang Huber, Athanasios Typas, Christian Widmer, Gunnar Rätsch, and
members of the Bork group for inspiring discussions. Additionally, we thank Yan Ping Yuan and the
EMBL Information Technology Core Facility for support with high-performance computing as well as
Bettina Haase, Dinko Pavlinic, and Bianka Baying and the EMBL Genomics Core Facility for sequencing
support. We acknowledge support with patient recruitment and characterization by Gilles Gatineau,
Michel Azizi, Thomas Aparicio, Marjan Djabbari, Yann Le Baleur, Isabelle Baumgartner, Hervé
Hagège, Anne Courillon-Mallet, Laurent Costes, Robert Benamouzig, Michael Levy, Maryan
Cavicchi, Elie Zrihen, Alain Rozenbaum, Gilles Trojmann, Damien Levoir, Olivier Pecriaux, Christophe
Lochet, Marc Parieto, Karen Leroy, Bijan Ghaleh, Philippe Le Corvoisier, Mariane Mozer, Philippe
Capelle, Benoit Coffin, Marc Gornet, Clare Abbenhardt, Verena Widmer, Stephanie Tosic, Christine
Fink, Manja Ghajar Rahimi, Torsten Kölsch, Judith Kammer, and Janina Biazeck and technical
support by Karine Le Roux, Sonia Garrigou, Julie Villemot, Sylvia Verdy, Philippe Langella, Jean
Pierre Furet, Joël Doré, Jean Pierre Carrau, Lin Zielske, Renate Skatula, Anett
Brendel, Hicham Mansour, Biba Nebbad, and Amine Amoura. This work has received funding through the
CancerBiome project (European Research Council project reference 268985), the METACARDIS project
(FP7-HEALTH-2012-INNOVATION-I-305312), the International Human Microbiome Standards project
(HEALTH-F4-2010-261376), a French LNCC 2004 grant, ACD grants, and in part through the PHRC 2009
Vatnimad grant.</p>
  </ack>
  <sec>
    <title>Author contributions</title>
    <p>PB, IS, JT, MvKD, AYV, GZ, and SS conceived and managed the project. AYV, AA, FB, NH, MKo, AL,
MS, PS-K, JB, CT, JTVN, MKl, CMU, MvKD, and IS recruited and diagnosed patients and collected
samples. AYV, JT, RH, JZ, and VB generated sequencing data. GZ, JT, AYV, SS, JRK, PB, PIC, DRM, and
TY designed and performed data analysis. GZ, PB, AYV, JT, SS, and JRK wrote the manuscript with
contributions from all other authors.</p>
  </sec>
  <sec>
    <title>Conflict of interest</title>
    <p>The authors declare that they have no conflict of interest.</p>
  </sec>
  <ref-list>
    <title>References</title>
    <ref id="b1">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Abubucker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Segata</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Goll</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schubert</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Izard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cantarel</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Rodriguez-Mueller</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zucker</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thiagarajan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Henrissat</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Methe</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Schloss</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Gevers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mitreva</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Huttenhower</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Metabolic reconstruction for metagenomic data and its application to the human
microbiome</article-title>
        <source>PLoS Comp Biol</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>e1002358</fpage>
      </element-citation>
    </ref>
    <ref id="b2">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allison</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Tekawa</surname>
            <given-names>IS</given-names>
          </name>
          <name>
            <surname>Ransom</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Adrain</surname>
            <given-names>AL</given-names>
          </name>
        </person-group>
        <article-title>A comparison of fecal occult-blood tests for colorectal-cancer
screening</article-title>
        <source>New Engl J Med</source>
        <year>1996</year>
        <volume>334</volume>
        <fpage>155</fpage>
        <lpage>159</lpage>
        <pub-id pub-id-type="pmid">8531970</pub-id>
      </element-citation>
    </ref>
    <ref id="b3">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allison</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Sakoda</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Levin</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Tucker</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Tekawa</surname>
            <given-names>IS</given-names>
          </name>
          <name>
            <surname>Cuff</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pauly</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Shlager</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Palitz</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>WK</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Ransohoff</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Selby</surname>
            <given-names>JV</given-names>
          </name>
        </person-group>
        <article-title>Screening for colorectal neoplasms with new fecal occult blood tests: update on
performance characteristics</article-title>
        <source>J Natl Cancer Inst</source>
        <year>2007</year>
        <volume>99</volume>
        <fpage>1462</fpage>
        <lpage>1470</lpage>
        <pub-id pub-id-type="pmid">17895475</pub-id>
      </element-citation>
    </ref>
    <ref id="b4">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Gish</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>Basic local alignment search tool</article-title>
        <source>J Mol Biol</source>
        <year>1990</year>
        <volume>215</volume>
        <fpage>403</fpage>
        <lpage>410</lpage>
        <pub-id pub-id-type="pmid">2231712</pub-id>
      </element-citation>
    </ref>
    <ref id="b5">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arthur</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Perez-Chanona</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Muhlbauer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tomkovich</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Uronis</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Abujamel</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Dogan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Rhodes</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Stintzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Simpson</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Keku</surname>
            <given-names>TO</given-names>
          </name>
          <name>
            <surname>Fodor</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Jobin</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Intestinal inflammation targets cancer-inducing activity of the
microbiota</article-title>
        <source>Science</source>
        <year>2012</year>
        <volume>338</volume>
        <fpage>120</fpage>
        <lpage>123</lpage>
        <pub-id pub-id-type="pmid">22903521</pub-id>
      </element-citation>
    </ref>
    <ref id="b6">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Harrington</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Foerstner</surname>
            <given-names>KU</given-names>
          </name>
          <name>
            <surname>Raes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>SmashCommunity: a metagenomic annotation and analysis tool</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>2977</fpage>
        <lpage>2978</lpage>
        <pub-id pub-id-type="pmid">20959381</pub-id>
      </element-citation>
    </ref>
    <ref id="b7">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Raes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pelletier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Le Paslier</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bruls</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Batto</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Bertalan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Borruel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Casellas</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gautier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kleerebezem</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kurokawa</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enterotypes of the human gut microbiome</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>473</volume>
        <fpage>174</fpage>
        <lpage>180</lpage>
        <pub-id pub-id-type="pmid">21508958</pub-id>
      </element-citation>
    </ref>
    <ref id="b8">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Raes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pelletier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Le Paslier</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bruls</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Batto</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Bertalan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Borruel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Casellas</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gautier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hansen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kleerebezem</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kurokawa</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Addendum: enterotypes of the human gut microbiome</article-title>
        <source>Nature</source>
        <year>2014</year>
        <volume>506</volume>
        <fpage>516</fpage>
        <pub-id pub-id-type="pmid">24572426</pub-id>
      </element-citation>
    </ref>
    <ref id="b10">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bergstrom</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Mucin-type O-glycans and their roles in intestinal homeostasis</article-title>
        <source>Glycobiology</source>
        <year>2013</year>
        <volume>23</volume>
        <fpage>1026</fpage>
        <lpage>1037</lpage>
        <pub-id pub-id-type="pmid">23752712</pub-id>
      </element-citation>
    </ref>
    <ref id="b11">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bernstein</surname>
            <given-names>CN</given-names>
          </name>
          <name>
            <surname>Blanchard</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Kliewer</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wajda</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer risk in patients with inflammatory bowel disease: a population-based
study</article-title>
        <source>Cancer</source>
        <year>2001</year>
        <volume>91</volume>
        <fpage>854</fpage>
        <lpage>862</lpage>
        <pub-id pub-id-type="pmid">11241255</pub-id>
      </element-citation>
    </ref>
    <ref id="b12">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boleij</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tjalsma</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Gut bacteria in health and disease: a survey on the interface between intestinal
microbiology and colorectal cancer</article-title>
        <source>Biol Rev Camb Philos Soc</source>
        <year>2012</year>
        <volume>87</volume>
        <fpage>701</fpage>
        <lpage>730</lpage>
        <pub-id pub-id-type="pmid">22296522</pub-id>
      </element-citation>
    </ref>
    <ref id="b13">
      <element-citation publication-type="journal">
        <collab>Cancer Genome Atlas Network</collab>
        <article-title>Comprehensive molecular characterization of human colon and rectal
cancer</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>487</volume>
        <fpage>330</fpage>
        <lpage>337</lpage>
        <pub-id pub-id-type="pmid">22810696</pub-id>
      </element-citation>
    </ref>
    <ref id="b14">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cantarel</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Coutinho</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Rancurel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bernard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lombard</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Henrissat</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The Carbohydrate-Active EnZymes database (CAZy): an expert resource for
Glycogenomics</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <fpage>D233</fpage>
        <lpage>D238</lpage>
        <pub-id pub-id-type="pmid">18838391</pub-id>
      </element-citation>
    </ref>
    <ref id="b15">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cantarel</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Lombard</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Henrissat</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Complex carbohydrate utilization by the healthy human microbiome</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e28742</fpage>
        <pub-id pub-id-type="pmid">22719820</pub-id>
      </element-citation>
    </ref>
    <ref id="b16">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Caporaso</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Lauber</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Berg-Lyons</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lozupone</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Turnbaugh</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Fierer</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Knight</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Global patterns of 16S rRNA diversity at a depth of millions of sequences per
sample</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>2011</year>
        <volume>108</volume>
        <issue>Suppl 1</issue>
        <fpage>4516</fpage>
        <lpage>4522</lpage>
        <pub-id pub-id-type="pmid">20534432</pub-id>
      </element-citation>
    </ref>
    <ref id="b17">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cario</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Brandwein</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Reinecker</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Podolsky</surname>
            <given-names>DK</given-names>
          </name>
        </person-group>
        <article-title>Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial
cell lines expressing Toll-like receptors</article-title>
        <source>J Immunol</source>
        <year>2000</year>
        <volume>164</volume>
        <fpage>966</fpage>
        <lpage>972</lpage>
        <pub-id pub-id-type="pmid">10623846</pub-id>
      </element-citation>
    </ref>
    <ref id="b18">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Castellarin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Warren</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Dreolini</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Krzywinski</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Strauss</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Barnes</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Watson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Holt</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium nucleatum</italic> infection is prevalent in human colorectal
carcinoma</article-title>
        <source>Genome Res</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>299</fpage>
        <lpage>306</lpage>
        <pub-id pub-id-type="pmid">22009989</pub-id>
      </element-citation>
    </ref>
    <ref id="b19">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Claesson</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Jeffery</surname>
            <given-names>IB</given-names>
          </name>
          <name>
            <surname>Conde</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Power</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Cusack</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Coakley</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lakshminarayanan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>O'Sullivan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Fitzgerald</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Deane</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Harnedy</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>O'Mahony</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>van Sinderen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brennan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Stanton</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gut microbiota composition correlates with diet and health in the
elderly</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>488</volume>
        <fpage>178</fpage>
        <lpage>184</lpage>
        <pub-id pub-id-type="pmid">22797518</pub-id>
      </element-citation>
    </ref>
    <ref id="b20">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cuevas-Ramos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Petit</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Marcq</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Boury</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Oswald</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nougayrede</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title><italic>Escherichia coli</italic> induces DNA damage in vivo and triggers genomic
instability in mammalian cells</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>11537</fpage>
        <lpage>11542</lpage>
        <pub-id pub-id-type="pmid">20534522</pub-id>
      </element-citation>
    </ref>
    <ref id="b21">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>David</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Maurice</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Carmody</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Gootenberg</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Button</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Wolfe</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Ling</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Devlin</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Varma</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fischbach</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Biddinger</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Dutton</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Turnbaugh</surname>
            <given-names>PJ</given-names>
          </name>
        </person-group>
        <article-title>Diet rapidly and reproducibly alters the human gut microbiome</article-title>
        <source>Nature</source>
        <year>2014</year>
        <volume>505</volume>
        <fpage>559</fpage>
        <lpage>563</lpage>
        <pub-id pub-id-type="pmid">24336217</pub-id>
      </element-citation>
    </ref>
    <ref id="b22">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dharmani</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Strauss</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ambrose</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chadee</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium nucleatum</italic> infection of colonic cells stimulates MUC2
mucin and tumor necrosis factor alpha</article-title>
        <source>Infect Immun</source>
        <year>2011</year>
        <volume>79</volume>
        <fpage>2597</fpage>
        <lpage>2607</lpage>
        <pub-id pub-id-type="pmid">21536792</pub-id>
      </element-citation>
    </ref>
    <ref id="b23">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Downes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wade</surname>
            <given-names>WG</given-names>
          </name>
        </person-group>
        <article-title><italic>Peptostreptococcus stomatis</italic> sp. nov., isolated from the human oral
cavity</article-title>
        <source>Int J Syst Evol Microbiol</source>
        <year>2006</year>
        <volume>56</volume>
        <fpage>751</fpage>
        <lpage>754</lpage>
        <pub-id pub-id-type="pmid">16585688</pub-id>
      </element-citation>
    </ref>
    <ref id="b24">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dutilh</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Backus</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>van Hijum</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Tjalsma</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Screening metatranscriptomes for toxin genes as functional drivers of human
colorectal cancer</article-title>
        <source>Best Pract Res Clin Gastroenterol</source>
        <year>2013</year>
        <volume>27</volume>
        <fpage>85</fpage>
        <lpage>99</lpage>
        <pub-id pub-id-type="pmid">23768555</pub-id>
      </element-citation>
    </ref>
    <ref id="b25">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eddy</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>Accelerated profile HMM searches</article-title>
        <source>PLoS Comput Biol</source>
        <year>2011</year>
        <volume>7</volume>
        <fpage>e1002195</fpage>
        <pub-id pub-id-type="pmid">22039361</pub-id>
      </element-citation>
    </ref>
    <ref id="b26">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Edgar</surname>
            <given-names>RC</given-names>
          </name>
        </person-group>
        <article-title>Search and clustering orders of magnitude faster than BLAST</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>2460</fpage>
        <lpage>2461</lpage>
        <pub-id pub-id-type="pmid">20709691</pub-id>
      </element-citation>
    </ref>
    <ref id="b27">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>El Kaoutari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Armougom</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Raoult</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Henrissat</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The abundance and variety of carbohydrate-active enzymes in the human gut
microbiota</article-title>
        <source>Nat Rev Microbiol</source>
        <year>2013</year>
        <volume>11</volume>
        <fpage>497</fpage>
        <lpage>504</lpage>
        <pub-id pub-id-type="pmid">23748339</pub-id>
      </element-citation>
    </ref>
    <ref id="b28">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Faivre</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dancourt</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Lejeune</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tazi</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Lamour</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gerard</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Dassonville</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bonithon-Kopp</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Reduction in colorectal cancer mortality by fecal occult blood screening in a French
controlled study</article-title>
        <source>Gastroenterology</source>
        <year>2004</year>
        <volume>126</volume>
        <fpage>1674</fpage>
        <lpage>1680</lpage>
        <pub-id pub-id-type="pmid">15188160</pub-id>
      </element-citation>
    </ref>
    <ref id="b29">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>XR</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>CJ</given-names>
          </name>
        </person-group>
        <article-title>LIBLINEAR: a library for large linear classification</article-title>
        <source>JMLR</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>1871</fpage>
        <lpage>1874</lpage>
      </element-citation>
    </ref>
    <ref id="b30">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fasano</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Toxins and the gut: role in human disease</article-title>
        <source>Gut</source>
        <year>2002</year>
        <volume>50</volume>
        <fpage>III9</fpage>
        <lpage>III14</lpage>
        <pub-id pub-id-type="pmid">11953326</pub-id>
      </element-citation>
    </ref>
    <ref id="b31">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Barry</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Abreu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Minie</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nolan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Delorey</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fennell</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ambrogio</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Berlin</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Blumenstiel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cibulskis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Friedrich</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Juhn</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Reilly</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Shammas</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stalker</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sykes</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A scalable, fully automated process for construction of sequence-ready human exome
targeted capture libraries</article-title>
        <source>Genome Biol</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>R1</fpage>
        <pub-id pub-id-type="pmid">21205303</pub-id>
      </element-citation>
    </ref>
    <ref id="b32">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flanagan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Schmid</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ebert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Soucek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kunicka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Liska</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bruha</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Neary</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Dezeeuw</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tommasino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jenab</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Prehn</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Hughes</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium nucleatum</italic> associates with stages of colorectal
neoplasia development, colorectal cancer and disease outcome</article-title>
        <source>Eur J Clin Microbiol Infect Dis</source>
        <year>2014</year>
        <volume>33</volume>
        <fpage>1381</fpage>
        <lpage>1390</lpage>
        <pub-id pub-id-type="pmid">24599709</pub-id>
      </element-citation>
    </ref>
    <ref id="b33">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Johansson</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Bradford</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thomsson</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>McGee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mansour</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>McDaniel</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Sferra</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hansson</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Braun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in
mice</article-title>
        <source>J Clin Invest</source>
        <year>2011</year>
        <volume>121</volume>
        <fpage>1657</fpage>
        <lpage>1666</lpage>
        <pub-id pub-id-type="pmid">21383503</pub-id>
      </element-citation>
    </ref>
    <ref id="b34">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Furet</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Firmesse</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gourmelon</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bridonneau</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mondot</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dore</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Corthier</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Comparative assessment of human and farm animal faecal microbiota using real-time
quantitative PCR</article-title>
        <source>FEMS Microbiol Ecol</source>
        <year>2009</year>
        <volume>68</volume>
        <fpage>351</fpage>
        <lpage>362</lpage>
        <pub-id pub-id-type="pmid">19302550</pub-id>
      </element-citation>
    </ref>
    <ref id="b35">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gerner</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Meyskens</surname>
            <given-names>FL</given-names>
            <suffix>Jr</suffix>
          </name>
        </person-group>
        <article-title>Polyamines and cancer: old molecules, new understanding</article-title>
        <source>Nat Rev Cancer</source>
        <year>2004</year>
        <volume>4</volume>
        <fpage>781</fpage>
        <lpage>792</lpage>
        <pub-id pub-id-type="pmid">15510159</pub-id>
      </element-citation>
    </ref>
    <ref id="b36">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gevers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kugathasan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Denson</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Vazquez-Baeza</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Van Treuren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Schwager</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Knights</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Yassour</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>XC</given-names>
          </name>
          <name>
            <surname>Kostic</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gonzalez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>McDonald</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Haberman</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rosh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The treatment-naive microbiome in new-onset Crohn's disease</article-title>
        <source>Cell Host Microbe</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>382</fpage>
        <lpage>392</lpage>
        <pub-id pub-id-type="pmid">24629344</pub-id>
      </element-citation>
    </ref>
    <ref id="b37">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Goodwin</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Destefano Shields</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Huso</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Murray-Stewart</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Hacker-Prietz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rabizadeh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Woster</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Sears</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Casero</surname>
            <given-names>RA</given-names>
            <suffix>Jr</suffix>
          </name>
        </person-group>
        <article-title>Polyamine catabolism contributes to enterotoxigenic <italic>Bacteroides
fragilis</italic>-induced colon tumorigenesis</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <year>2011</year>
        <volume>108</volume>
        <fpage>15354</fpage>
        <lpage>15359</lpage>
        <pub-id pub-id-type="pmid">21876161</pub-id>
      </element-citation>
    </ref>
    <ref id="b38">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hol</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>van Leerdam</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>van Ballegooijen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>van Vuuren</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>van Dekken</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Reijerink</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>van der Togt</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Habbema</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Kuipers</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Screening for colorectal cancer: randomised trial comparing guaiac-based and
immunochemical faecal occult blood testing and flexible sigmoidoscopy</article-title>
        <source>Gut</source>
        <year>2010</year>
        <volume>59</volume>
        <fpage>62</fpage>
        <lpage>68</lpage>
        <pub-id pub-id-type="pmid">19671542</pub-id>
      </element-citation>
    </ref>
    <ref id="b39">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hsu</surname>
            <given-names>RY</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Spicer</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Giannias</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ferri</surname>
            <given-names>LE</given-names>
          </name>
        </person-group>
        <article-title>LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1
integrin-mediated cell adhesion and liver metastasis</article-title>
        <source>Cancer Res</source>
        <year>2011</year>
        <volume>71</volume>
        <fpage>1989</fpage>
        <lpage>1998</lpage>
        <pub-id pub-id-type="pmid">21363926</pub-id>
      </element-citation>
    </ref>
    <ref id="b40">
      <element-citation publication-type="journal">
        <collab>Human Microbiome Project Consortium</collab>
        <article-title>Structure, function and diversity of the healthy human microbiome</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>486</volume>
        <fpage>207</fpage>
        <lpage>214</lpage>
        <pub-id pub-id-type="pmid">22699609</pub-id>
      </element-citation>
    </ref>
    <ref id="b41">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Imperiale</surname>
            <given-names>TF</given-names>
          </name>
          <name>
            <surname>Ransohoff</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Itzkowitz</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Levin</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Lavin</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lidgard</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Ahlquist</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>BM</given-names>
          </name>
        </person-group>
        <article-title>Multitarget stool DNA testing for colorectal-cancer screening</article-title>
        <source>New Engl J Med</source>
        <year>2014</year>
        <volume>370</volume>
        <fpage>1287</fpage>
        <lpage>1297</lpage>
        <pub-id pub-id-type="pmid">24645800</pub-id>
      </element-citation>
    </ref>
    <ref id="b42">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Center</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Global cancer statistics</article-title>
        <source>CA Cancer J Clin</source>
        <year>2011</year>
        <volume>61</volume>
        <fpage>69</fpage>
        <lpage>90</lpage>
        <pub-id pub-id-type="pmid">21296855</pub-id>
      </element-citation>
    </ref>
    <ref id="b43">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Araki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hirakawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Itoh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Katayama</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kawashima</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Okuda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tokimatsu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamanishi</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>KEGG for linking genomes to life and the environment</article-title>
        <source>Nucleic Acids Res</source>
        <year>2008</year>
        <volume>36</volume>
        <fpage>D480</fpage>
        <lpage>D484</lpage>
        <pub-id pub-id-type="pmid">18077471</pub-id>
      </element-citation>
    </ref>
    <ref id="b44">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karlsson</surname>
            <given-names>FH</given-names>
          </name>
          <name>
            <surname>Tremaroli</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Nookaew</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Bergstrom</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Behre</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Fagerberg</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Backhed</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Gut metagenome in European women with normal, impaired and diabetic glucose
control</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>498</volume>
        <fpage>99</fpage>
        <lpage>103</lpage>
        <pub-id pub-id-type="pmid">23719380</pub-id>
      </element-citation>
    </ref>
    <ref id="b45">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knights</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Parfrey</surname>
            <given-names>LW</given-names>
          </name>
          <name>
            <surname>Zaneveld</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lozupone</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Knight</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Human-associated microbial signatures: examining their predictive
value</article-title>
        <source>Cell Host Microbe</source>
        <year>2011</year>
        <volume>10</volume>
        <fpage>292</fpage>
        <lpage>296</lpage>
        <pub-id pub-id-type="pmid">22018228</pub-id>
      </element-citation>
    </ref>
    <ref id="b46">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koeth</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Levison</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Buffa</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Org</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sheehy</surname>
            <given-names>BT</given-names>
          </name>
          <name>
            <surname>Britt</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Didonato</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Warrier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>WH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes
atherosclerosis</article-title>
        <source>Nat Med</source>
        <year>2013</year>
        <volume>19</volume>
        <fpage>576</fpage>
        <lpage>585</lpage>
        <pub-id pub-id-type="pmid">23563705</pub-id>
      </element-citation>
    </ref>
    <ref id="b47">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koropatkin</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Martens</surname>
            <given-names>EC</given-names>
          </name>
        </person-group>
        <article-title>How glycan metabolism shapes the human gut microbiota</article-title>
        <source>Nat Rev Microbiol</source>
        <year>2012</year>
        <volume>10</volume>
        <fpage>323</fpage>
        <lpage>335</lpage>
        <pub-id pub-id-type="pmid">22491358</pub-id>
      </element-citation>
    </ref>
    <ref id="b48">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kostic</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Chun</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Robertson</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Glickman</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Gallini</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Michaud</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clancy</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Lochhead</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hold</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>El-Omar</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Brenner</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Meyerson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garrett</surname>
            <given-names>WS</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium nucleatum</italic> potentiates intestinal tumorigenesis and
modulates the tumor-immune microenvironment</article-title>
        <source>Cell Host Microbe</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>207</fpage>
        <lpage>215</lpage>
        <pub-id pub-id-type="pmid">23954159</pub-id>
      </element-citation>
    </ref>
    <ref id="b49">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kostic</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Gevers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pedamallu</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Michaud</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duke</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Earl</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Ojesina</surname>
            <given-names>AI</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bass</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Tabernero</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Baselga</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Shivdasani</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Ogino</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Birren</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Huttenhower</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Garrett</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Meyerson</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Genomic analysis identifies association of <italic>Fusobacterium</italic> with
colorectal carcinoma</article-title>
        <source>Genome Res</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>292</fpage>
        <lpage>298</lpage>
        <pub-id pub-id-type="pmid">22009990</pub-id>
      </element-citation>
    </ref>
    <ref id="b50">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kultima</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Sunagawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>MOCAT: a metagenomics assembly and gene prediction toolkit</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e47656</fpage>
        <pub-id pub-id-type="pmid">23082188</pub-id>
      </element-citation>
    </ref>
    <ref id="b51">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Chatelier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Prifti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hildebrand</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Falony</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Almeida</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Batto</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Leonard</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Burgdorf</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Grarup</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Jorgensen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brandslund</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Juncker</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Bertalan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Levenez</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>500</volume>
        <fpage>541</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="pmid">23985870</pub-id>
      </element-citation>
    </ref>
    <ref id="b52">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>EH</given-names>
          </name>
          <name>
            <surname>Chun</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>DH</given-names>
          </name>
        </person-group>
        <article-title>Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker
for early detection of colorectal cancer</article-title>
        <source>Clin Cancer Res</source>
        <year>2009</year>
        <volume>15</volume>
        <fpage>6185</fpage>
        <lpage>6191</lpage>
        <pub-id pub-id-type="pmid">19773381</pub-id>
      </element-citation>
    </ref>
    <ref id="b53">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Levin</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lieberman</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>McFarland</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Andrews</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Dash</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Giardiello</surname>
            <given-names>FM</given-names>
          </name>
          <name>
            <surname>Glick</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Levin</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Pickhardt</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rex</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Thorson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Winawer</surname>
            <given-names>SJ</given-names>
          </name>
        </person-group>
        <collab>American Cancer Society Colorectal Cancer Advisory G, Force USM-ST, American College of
Radiology Colon Cancer C</collab>
        <article-title>Screening and surveillance for the early detection of colorectal cancer and
adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society
Task Force on Colorectal Cancer, and the American College of Radiology</article-title>
        <source>CA Cancer J Clin</source>
        <year>2008</year>
        <volume>58</volume>
        <fpage>130</fpage>
        <lpage>160</lpage>
        <pub-id pub-id-type="pmid">18322143</pub-id>
      </element-citation>
    </ref>
    <ref id="b54">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kristiansen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>SOAP: short oligonucleotide alignment program</article-title>
        <source>Bioinformatics</source>
        <year>2008</year>
        <volume>24</volume>
        <fpage>713</fpage>
        <lpage>714</lpage>
        <pub-id pub-id-type="pmid">18227114</pub-id>
      </element-citation>
    </ref>
    <ref id="b55">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Godzik</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cd-hit: a fast program for clustering and comparing large sets of protein or
nucleotide sequences</article-title>
        <source>Bioinformatics</source>
        <year>2006</year>
        <volume>22</volume>
        <fpage>1658</fpage>
        <lpage>1659</lpage>
        <pub-id pub-id-type="pmid">16731699</pub-id>
      </element-citation>
    </ref>
    <ref id="b56">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lichtenstein</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Holm</surname>
            <given-names>NV</given-names>
          </name>
          <name>
            <surname>Verkasalo</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Iliadou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kaprio</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Koskenvuo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pukkala</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Skytthe</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hemminki</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Environmental and heritable factors in the causation of cancer–analyses of
cohorts of twins from Sweden, Denmark, and Finland</article-title>
        <source>N Engl J Med</source>
        <year>2000</year>
        <volume>343</volume>
        <fpage>78</fpage>
        <lpage>85</lpage>
        <pub-id pub-id-type="pmid">10891514</pub-id>
      </element-citation>
    </ref>
    <ref id="b57">
      <element-citation publication-type="other">
        <person-group person-group-type="author">
          <name>
            <surname>Mansour</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sobhani</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <year>2009</year>
        <comment>Method, process, and kit for diagnosis or prognosis of colorectal cancer. WO 2009095596 A2.
Paris, France</comment>
      </element-citation>
    </ref>
    <ref id="b58">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marchesi</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Dutilh</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Roelofs</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Boleij</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tjalsma</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Towards the human colorectal cancer microbiome</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e20447</fpage>
        <pub-id pub-id-type="pmid">21647227</pub-id>
      </element-citation>
    </ref>
    <ref id="b59">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Martel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Franceschi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vignat</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Plummer</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Global burden of cancers attributable to infections in 2008: a review and synthetic
analysis</article-title>
        <source>Lancet Oncol</source>
        <year>2012</year>
        <volume>13</volume>
        <fpage>607</fpage>
        <lpage>615</lpage>
        <pub-id pub-id-type="pmid">22575588</pub-id>
      </element-citation>
    </ref>
    <ref id="b60">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McCoy</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Araujo-Perez</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Azcarate-Peril</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Sandler</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Keku</surname>
            <given-names>TO</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium</italic> is associated with colorectal adenomas</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e53653</fpage>
        <pub-id pub-id-type="pmid">23335968</pub-id>
      </element-citation>
    </ref>
    <ref id="b61">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McGuckin</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Linden</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Sutton</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Florin</surname>
            <given-names>TH</given-names>
          </name>
        </person-group>
        <article-title>Mucin dynamics and enteric pathogens</article-title>
        <source>Nat Rev Microbiol</source>
        <year>2011</year>
        <volume>9</volume>
        <fpage>265</fpage>
        <lpage>278</lpage>
        <pub-id pub-id-type="pmid">21407243</pub-id>
      </element-citation>
    </ref>
    <ref id="b62">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Sunagawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zeller</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Accurate and universal delineation of prokaryotic species</article-title>
        <source>Nat Methods</source>
        <year>2013</year>
        <volume>10</volume>
        <fpage>881</fpage>
        <lpage>884</lpage>
        <pub-id pub-id-type="pmid">23892899</pub-id>
      </element-citation>
    </ref>
    <ref id="b63">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O'Connell</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Maggard</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ko</surname>
            <given-names>CY</given-names>
          </name>
        </person-group>
        <article-title>Colon cancer survival rates with the new American Joint Committee on Cancer sixth
edition staging</article-title>
        <source>J Natl Cancer Inst</source>
        <year>2004</year>
        <volume>96</volume>
        <fpage>1420</fpage>
        <lpage>1425</lpage>
        <pub-id pub-id-type="pmid">15467030</pub-id>
      </element-citation>
    </ref>
    <ref id="b64">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Papa</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Docktor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smillie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Preheim</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Gevers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Giannoukos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ciulla</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tabbaa</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ingram</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schauer</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>DV</given-names>
          </name>
          <name>
            <surname>Korzenik</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Xavier</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Bousvaros</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Alm</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Non-invasive mapping of the gastrointestinal microbiota identifies children with
inflammatory bowel disease</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e39242</fpage>
        <pub-id pub-id-type="pmid">22768065</pub-id>
      </element-citation>
    </ref>
    <ref id="b65">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Park</surname>
            <given-names>SN</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Kook</surname>
            <given-names>JK</given-names>
          </name>
        </person-group>
        <article-title>Development of quantitative real-time PCR primers for detecting 42 oral bacterial
species</article-title>
        <source>Arch Microbiol</source>
        <year>2013</year>
        <volume>195</volume>
        <fpage>473</fpage>
        <lpage>482</lpage>
        <pub-id pub-id-type="pmid">23689247</pub-id>
      </element-citation>
    </ref>
    <ref id="b66">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Png</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Linden</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Gilshenan</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Zoetendal</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>McSweeney</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Sly</surname>
            <given-names>LI</given-names>
          </name>
          <name>
            <surname>McGuckin</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Florin</surname>
            <given-names>TH</given-names>
          </name>
        </person-group>
        <article-title>Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro
utilization of mucin by other bacteria</article-title>
        <source>Am J Gastroenterol</source>
        <year>2010</year>
        <volume>105</volume>
        <fpage>2420</fpage>
        <lpage>2428</lpage>
        <pub-id pub-id-type="pmid">20648002</pub-id>
      </element-citation>
    </ref>
    <ref id="b67">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pruesse</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Quast</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Knittel</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>BM</given-names>
          </name>
          <name>
            <surname>Ludwig</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Peplies</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Glockner</surname>
            <given-names>FO</given-names>
          </name>
        </person-group>
        <article-title>SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA
sequence data compatible with ARB</article-title>
        <source>Nucleic Acids Res</source>
        <year>2007</year>
        <volume>35</volume>
        <fpage>7188</fpage>
        <lpage>7196</lpage>
        <pub-id pub-id-type="pmid">17947321</pub-id>
      </element-citation>
    </ref>
    <ref id="b68">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Raes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Burgdorf</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Manichanh</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pons</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Levenez</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Yamada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A human gut microbial gene catalogue established by metagenomic
sequencing</article-title>
        <source>Nature</source>
        <year>2010</year>
        <volume>464</volume>
        <fpage>59</fpage>
        <lpage>65</lpage>
        <pub-id pub-id-type="pmid">20203603</pub-id>
      </element-citation>
    </ref>
    <ref id="b69">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Guan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jie</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A metagenome-wide association study of gut microbiota in type 2
diabetes</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>490</volume>
        <fpage>55</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="pmid">23023125</pub-id>
      </element-citation>
    </ref>
    <ref id="b70">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Robin</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Turck</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hainard</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tiberti</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lisacek</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>pROC: an open-source package for R and S+ to analyze and compare ROC
curves</article-title>
        <source>BMC Bioinformatics</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>77</fpage>
        <pub-id pub-id-type="pmid">21414208</pub-id>
      </element-citation>
    </ref>
    <ref id="b71">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rubinstein</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>YW</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium nucleatum</italic> promotes colorectal carcinogenesis by
modulating E-cadherin/beta-catenin signaling via its FadA adhesin</article-title>
        <source>Cell Host Microbe</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>195</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="pmid">23954158</pub-id>
      </element-citation>
    </ref>
    <ref id="b72">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schloissnig</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sunagawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mitreva</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Kultima</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kota</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sunyaev</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Weinstock</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Genomic variation landscape of the human gut microbiome</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>493</volume>
        <fpage>45</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="pmid">23222524</pub-id>
      </element-citation>
    </ref>
    <ref id="b73">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schloss</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Westcott</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Ryabin</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Hartmann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hollister</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Lesniewski</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Oakley</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Parks</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Sahl</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Stres</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Thallinger</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Van Horn</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>CF</given-names>
          </name>
        </person-group>
        <article-title>Introducing mothur: open-source, platform-independent, community-supported software
for describing and comparing microbial communities</article-title>
        <source>Appl Environ Microbiol</source>
        <year>2009</year>
        <volume>75</volume>
        <fpage>7537</fpage>
        <lpage>7541</lpage>
        <pub-id pub-id-type="pmid">19801464</pub-id>
      </element-citation>
    </ref>
    <ref id="b74">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shafquat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Joice</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Simmons</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Huttenhower</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Functional and phylogenetic assembly of microbial communities in the human
microbiome</article-title>
        <source>Trends Microbiol</source>
        <year>2014</year>
        <volume>22</volume>
        <fpage>261</fpage>
        <lpage>266</lpage>
        <pub-id pub-id-type="pmid">24618403</pub-id>
      </element-citation>
    </ref>
    <ref id="b75">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sievers</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wilm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dineen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Karplus</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McWilliam</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Remmert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Soding</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Higgins</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Fast, scalable generation of high-quality protein multiple sequence alignments using
Clustal Omega</article-title>
        <source>Mol Syst Biol</source>
        <year>2011</year>
        <volume>7</volume>
        <fpage>539</fpage>
        <pub-id pub-id-type="pmid">21988835</pub-id>
      </element-citation>
    </ref>
    <ref id="b76">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Smialowski</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Frishman</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kramer</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Pitfalls of supervised feature selection</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>440</fpage>
        <lpage>443</lpage>
        <pub-id pub-id-type="pmid">19880370</pub-id>
      </element-citation>
    </ref>
    <ref id="b77">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sobhani</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Roudot-Thoraval</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Roperch</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Letulle</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Langella</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Corthier</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tran Van Nhieu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Furet</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title>Microbial dysbiosis in colorectal cancer (CRC) patients</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>e16393</fpage>
        <pub-id pub-id-type="pmid">21297998</pub-id>
      </element-citation>
    </ref>
    <ref id="b78">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sonnenburg</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leip</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Westover</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Weatherford</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Buhler</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>JI</given-names>
          </name>
        </person-group>
        <article-title>Glycan foraging in vivo by an intestine-adapted bacterial symbiont</article-title>
        <source>Science</source>
        <year>2005</year>
        <volume>307</volume>
        <fpage>1955</fpage>
        <lpage>1959</lpage>
        <pub-id pub-id-type="pmid">15790854</pub-id>
      </element-citation>
    </ref>
    <ref id="b79">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Strauss</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kaplan</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Rioux</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Panaccione</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Devinney</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Invasive potential of gut mucosa-derived <italic>Fusobacterium nucleatum</italic>
positively correlates with IBD status of the host</article-title>
        <source>Inflamm Bowel Dis</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>1971</fpage>
        <lpage>1978</lpage>
        <pub-id pub-id-type="pmid">21830275</pub-id>
      </element-citation>
    </ref>
    <ref id="b80">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sunagawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mende</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Zeller</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Izquierdo-Carrasco</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Berger</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Kultima</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Coelho</surname>
            <given-names>LP</given-names>
          </name>
          <name>
            <surname>Arumugam</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tap</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Rasmussen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brunak</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pedersen</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Guarner</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>de Vos</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dore</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ehrlich</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Stamatakis</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Metagenomic species profiling using universal phylogenetic marker
genes</article-title>
        <source>Nat Methods</source>
        <year>2013</year>
        <volume>10</volume>
        <fpage>1196</fpage>
        <lpage>1199</lpage>
        <pub-id pub-id-type="pmid">24141494</pub-id>
      </element-citation>
    </ref>
    <ref id="b81">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tahara</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Maruyama</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Garriga</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jelinek</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yamano</surname>
            <given-names>HO</given-names>
          </name>
          <name>
            <surname>Sugai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>An</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Shureiqi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Toyota</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Estecio</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Issa</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title><italic>Fusobacterium</italic> in colonic flora and molecular features of colorectal
carcinoma</article-title>
        <source>Cancer Res</source>
        <year>2014</year>
        <volume>74</volume>
        <fpage>1311</fpage>
        <lpage>1318</lpage>
        <pub-id pub-id-type="pmid">24385213</pub-id>
      </element-citation>
    </ref>
    <ref id="b82">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>XY</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>YQ</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Expression and functional research of TLR4 in human colon carcinoma</article-title>
        <source>Am J Med Sci</source>
        <year>2010</year>
        <volume>339</volume>
        <fpage>319</fpage>
        <lpage>326</lpage>
        <pub-id pub-id-type="pmid">20228668</pub-id>
      </element-citation>
    </ref>
    <ref id="b83">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tibshirani</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Regression shinkage and selection via the Lasso</article-title>
        <source>J R Statist Soc B</source>
        <year>1996</year>
        <volume>58</volume>
        <fpage>267</fpage>
        <lpage>288</lpage>
      </element-citation>
    </ref>
    <ref id="b84">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trosset</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Priebe</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>The out-of-sample problem for classical multidimensional scaling</article-title>
        <source>Comput Stat Data Anal</source>
        <year>2006</year>
        <volume>52</volume>
        <fpage>4635</fpage>
        <lpage>4642</lpage>
      </element-citation>
    </ref>
    <ref id="b85">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Turnbaugh</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Hamady</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yatsunenko</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cantarel</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Duncan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ley</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Sogin</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Roe</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Affourtit</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Egholm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Henrissat</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Heath</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Knight</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>JI</given-names>
          </name>
        </person-group>
        <article-title>A core gut microbiome in obese and lean twins</article-title>
        <source>Nature</source>
        <year>2009</year>
        <volume>457</volume>
        <fpage>480</fpage>
        <lpage>484</lpage>
        <pub-id pub-id-type="pmid">19043404</pub-id>
      </element-citation>
    </ref>
    <ref id="b86">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Turnbaugh</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Ley</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Mahowald</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Magrini</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Mardis</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>JI</given-names>
          </name>
        </person-group>
        <article-title>An obesity-associated gut microbiome with increased capacity for energy
harvest</article-title>
        <source>Nature</source>
        <year>2006</year>
        <volume>444</volume>
        <fpage>1027</fpage>
        <lpage>1031</lpage>
        <pub-id pub-id-type="pmid">17183312</pub-id>
      </element-citation>
    </ref>
    <ref id="b87">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Velcich</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Heyer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fragale</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nicholas</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Viani</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kucherlapati</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lipkin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Augenlicht</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Colorectal cancer in mice genetically deficient in the mucin Muc2</article-title>
        <source>Science</source>
        <year>2002</year>
        <volume>295</volume>
        <fpage>1726</fpage>
        <lpage>1729</lpage>
        <pub-id pub-id-type="pmid">11872843</pub-id>
      </element-citation>
    </ref>
    <ref id="b88">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Papadopoulos</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Velculescu</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Diaz</surname>
            <given-names>LA</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
        </person-group>
        <article-title>Cancer genome landscapes</article-title>
        <source>Science</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>1546</fpage>
        <lpage>1558</lpage>
        <pub-id pub-id-type="pmid">23539594</pub-id>
      </element-citation>
    </ref>
    <ref id="b89">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Vos</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Nieuwdorp</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Genomics: a gut prediction</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>498</volume>
        <fpage>48</fpage>
        <lpage>49</lpage>
        <pub-id pub-id-type="pmid">23719383</pub-id>
      </element-citation>
    </ref>
    <ref id="b90">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Garrity</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Tiedje</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>JR</given-names>
          </name>
        </person-group>
        <article-title>Naive Bayesian classifier for rapid assignment of rRNA sequences into the new
bacterial taxonomy</article-title>
        <source>Appl Environ Microbiol</source>
        <year>2007</year>
        <volume>73</volume>
        <fpage>5261</fpage>
        <lpage>5267</lpage>
        <pub-id pub-id-type="pmid">17586664</pub-id>
      </element-citation>
    </ref>
    <ref id="b91">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Warren</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Pleasance</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Watson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Cochrane</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Holt</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>Co-occurrence of anaerobic bacteria in colorectal carcinomas</article-title>
        <source>Microbiome</source>
        <year>2013</year>
        <volume>1</volume>
        <fpage>16</fpage>
        <pub-id pub-id-type="pmid">24450771</pub-id>
      </element-citation>
    </ref>
    <ref id="b92">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weir</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Manter</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Sheflin</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Barnett</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Heuberger</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Ryan</surname>
            <given-names>EP</given-names>
          </name>
        </person-group>
        <article-title>Stool microbiome and metabolome differences between colorectal cancer patients and
healthy adults</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>e70803</fpage>
        <pub-id pub-id-type="pmid">23940645</pub-id>
      </element-citation>
    </ref>
    <ref id="b93">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rhee</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Albesiano</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rabizadeh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>HR</given-names>
          </name>
          <name>
            <surname>Huso</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Brancati</surname>
            <given-names>FL</given-names>
          </name>
          <name>
            <surname>Wick</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>McAllister</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Housseau</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pardoll</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Sears</surname>
            <given-names>CL</given-names>
          </name>
        </person-group>
        <article-title>A human colonic commensal promotes colon tumorigenesis via activation of T helper
type 17 T cell responses</article-title>
        <source>Nat Med</source>
        <year>2009</year>
        <volume>15</volume>
        <fpage>1016</fpage>
        <lpage>1022</lpage>
        <pub-id pub-id-type="pmid">19701202</pub-id>
      </element-citation>
    </ref>
    <ref id="b94">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Mao</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>dbCAN: a web resource for automated carbohydrate-active enzyme
annotation</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>W445</fpage>
        <lpage>W451</lpage>
        <pub-id pub-id-type="pmid">22645317</pub-id>
      </element-citation>
    </ref>
    <ref id="b95">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zackular</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ruffin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schloss</surname>
            <given-names>PD</given-names>
          </name>
        </person-group>
        <article-title>The human gut microbiome as a screening tool for colorectal cancer</article-title>
        <source>Cancer Prev Res (Phila)</source>
        <year>2014</year>
        <volume>7</volume>
        <fpage>1112</fpage>
        <lpage>1121</lpage>
        <pub-id pub-id-type="pmid">25104642</pub-id>
      </element-citation>
    </ref>
    <ref id="b96">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zavoral</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Suchanek</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zavada</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dusek</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Muzik</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Seifert</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Fric</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Colorectal cancer screening in Europe</article-title>
        <source>World J Gastroenterol</source>
        <year>2009</year>
        <volume>15</volume>
        <fpage>5907</fpage>
        <lpage>5915</lpage>
        <pub-id pub-id-type="pmid">20014454</pub-id>
      </element-citation>
    </ref>
    <ref id="b97">
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Lomsadze</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Borodovsky</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Ab initio gene identification in metagenomic sequences</article-title>
        <source>Nucleic Acids Res</source>
        <year>2010</year>
        <volume>38</volume>
        <fpage>e132</fpage>
        <pub-id pub-id-type="pmid">20403810</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec sec-type="supplementary-material">
    <title>Supporting Information</title>
    <p><bold>Supplementary information</bold> for this article is available online: <ext-link ext-link-type="uri" xlink:href="http://msb.embopress.org">http://msb.embopress.org</ext-link></p>
    <supplementary-material content-type="local-data" id="SD1">
      <caption>
        <p>Supplementary Information</p>
      </caption>
      <media mimetype="application" mime-subtype="pdf" xlink:href="msb0010-0766-sd1.pdf" xlink:type="simple" id="d35e8086" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD2">
      <caption>
        <p>Supplementary Dataset S1</p>
      </caption>
      <media mimetype="application" mime-subtype="xlsx" xlink:href="msb0010-0766-sd2.xlsx" xlink:type="simple" id="d35e8091" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD3">
      <caption>
        <p>Supplementary Dataset S2</p>
      </caption>
      <media mimetype="application" mime-subtype="xlsx" xlink:href="msb0010-0766-sd3.xlsx" xlink:type="simple" id="d35e8096" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD4">
      <caption>
        <p>Supplementary Dataset S3</p>
      </caption>
      <media mimetype="application" mime-subtype="xlsx" xlink:href="msb0010-0766-sd4.xlsx" xlink:type="simple" id="d35e8101" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD5">
      <caption>
        <p>Review Process File</p>
      </caption>
      <media mimetype="application" mime-subtype="pdf" xlink:href="msb0010-0766-sd5.pdf" xlink:type="simple" id="d35e8106" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD6">
      <caption>
        <p>Source Data for Figure 1</p>
      </caption>
      <media mimetype="application" mime-subtype="xlsx" xlink:href="msb0010-0766-sd6.xlsx" xlink:type="simple" id="d35e8111" position="anchor"/>
    </supplementary-material>
  </sec>
</back>
